rfhg_182703.1

Basic information about the TSS

---

TSS ID: rfhg_182703.1 TSS ID(Version3): hg_153517.1 hg_153516.1 Species: human Chr: chr16		Start: 29808083 End: 29808150 Strand: +
Source datasets	FANTOM5|PRJNA548673|PRJNA401781|PRJNA615891|PRJNA4843412 |DRA013844
Protocol	CAGE|oligo_capping|SLIC_CAGE|RAMPAGE|NETCAGE|ReCappable-seq
TSS cluster detected*	9

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2857974,EH38E1810943)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000569978.1:0 ENST00000568282.1:0 GeneID: 4150 HGNC/MGI_ID: HGNC:6914 UniProt_ID: I3L0M3 I3L411 Nearer transcript ids and distances: ENST00000568544.5:-32 ENST00000562557.5:-154 ENST00000563012.1:-265 ENST00000565777.1:270 ENST00000568411.5:-308 DQ591143:-402 DQ582470:466 DQ590938:492 view more...

Gene_name: MYC associated zinc finger protein Gene_symbol: MAZ Gene_synonyms: Pur-1 ZF87 ZNF801 Zif87 Gene_source: HGNC:6914

TATA-Box annotation

---

Distance to TSS:	1587
Nearest PromoterID:	NR_074080
Entrez ID:	4150
Nearest Unigene:	Hs.23650
Nearest Refseq:	NM_002383
Nearest Ensembl:	ENSG00000103495
Gene Name:	MYC associated zinc finger protein
Gene Alias:	PUR1|Pur-1|SAF-1|SAF-2|SAF-3|ZF87|ZNF801|Zif87
Gene Type:	protein-coding
CpG%:	0.059701
GC%:	0.661765
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MAZ p2@MAZ p3@MAZ p4@MAZ p5@MAZ p7@MAZ p8@MAZ p9@MAZ p10@MAZ
Sample		p1@MAZ	p2@MAZ	p3@MAZ	p4@MAZ	p5@MAZ	p7@MAZ	p8@MAZ	p9@MAZ	p10@MAZ
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	81.23	34.87	11.30	9.74	110.06	1.75	2.14	9.35	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	89.63	37.83	14.97	9.91	108.24	1.21	1.01	10.12	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	70.60	36.84	11.77	7.33	104.75	1.74	1.93	10.03	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	90.65	35.34	13.93	10.40	90.23	0.62	2.08	7.07	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	91.56	39.14	11.02	10.35	101.46	1.35	1.57	7.87	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	71.32	24.81	13.95	5.62	104.85	1.36	2.33	8.72	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	95.22	37.48	20.26	12.42	110.90	1.53	1.74	12.20	1.96
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	61.52	34.64	16.23	10.90	121.84	1.94	1.70	8.72	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	87.62	43.38	17.74	15.82	125.24	1.71	1.07	10.47	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	51.59	24.92	17.39	9.85	103.75	1.74	4.06	9.27	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	45.68	20.21	11.32	7.68	107.53	0.81	4.45	7.28	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.17	23.17	14.23	8.94	108.55	2.44	2.03	9.35	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.03	21.60	18.86	19.67	8.70	2.42	3.06	2.10	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	33.98	14.13	14.73	10.37	7.37	2.10	2.41	1.50	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.28	21.74	20.20	17.13	2.85	2.42	1.98	1.54	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	40.49	18.86	20.37	15.59	7.29	1.51	1.76	3.02	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.29	15.51	13.10	14.85	5.68	1.53	1.75	1.31	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.01	17.72	15.61	10.12	4.64	1.27	2.11	1.27	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.12	12.80	12.80	10.13	8.00	3.20	1.07	2.13	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.87	15.50	18.50	14.14	7.07	2.26	2.11	1.81	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.69	15.10	13.77	16.17	5.88	2.14	2.41	1.87	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.83	12.95	15.54	11.05	6.04	2.59	3.11	2.42	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	33.09	13.44	13.05	13.31	6.85	2.07	2.46	2.59	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.04	19.41	20.14	20.38	8.25	2.43	1.94	3.64	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.79	18.32	17.03	16.25	9.03	1.81	2.58	2.32	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.25	17.41	21.52	12.34	7.28	3.48	2.22	2.85	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	15.93	13.74	7.69	6.59	2.20	1.10	2.75	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.72	18.62	20.98	16.27	9.43	3.77	1.89	4.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.24	14.54	15.67	12.92	10.01	1.62	1.94	3.55	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	41.44	15.74	13.93	15.02	10.50	0.90	1.99	2.90	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.33	12.98	14.86	10.05	7.96	1.26	2.09	2.72	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	33.21	15.63	15.63	7.82	7.23	1.56	0.59	2.15	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	31.23	12.45	15.19	9.92	7.39	1.48	1.27	2.32	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.36	3.63	6.10	4.12	8.58	0.66	1.65	2.47	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.34	18.14	15.33	12.72	8.60	0.37	0.56	2.62	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	43.88	13.22	15.71	12.07	8.05	1.53	0.57	2.30	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.63	12.47	14.31	11.24	7.56	0.82	1.02	3.07	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.04	13.30	11.28	10.88	8.46	0.81	0.81	2.82	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.98	15.67	12.96	9.99	6.21	0.81	0.00	1.35	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.01	11.04	13.44	8.88	5.28	0.24	1.20	1.68	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.94	16.23	13.88	11.29	7.29	1.41	0.94	4.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.37	5.86	7.32	5.27	8.34	0.59	1.17	2.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.79	11.39	13.50	9.70	6.75	0.84	2.11	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	32.87	14.86	13.64	11.54	6.82	1.40	1.57	1.92	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.34	12.65	14.46	12.65	7.43	1.61	1.41	3.01	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	35.83	14.89	17.91	10.00	5.82	3.02	3.26	1.86	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	43.18	17.75	13.67	13.19	7.20	1.68	2.88	3.12	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	35.17	15.80	14.90	9.84	5.36	2.68	2.38	1.49	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.55	15.08	15.08	10.29	7.18	1.44	1.91	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.09	11.53	12.94	7.48	4.04	2.83	1.42	1.01	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	20.09	10.04	9.22	5.74	3.89	1.23	2.66	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.68	10.67	9.56	7.56	4.45	2.00	2.22	1.33	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	5.68	5.32	6.74	5.68	0.71	1.06	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.92	3.31	6.30	1.99	5.63	1.33	0.99	1.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	0.84	4.19	2.52	3.36	2.52	3.36	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.18	2.30	4.59	2.76	4.59	1.38	0.92	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.36	5.19	8.43	5.19	3.57	1.94	0.97	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.48	8.67	8.03	6.10	2.25	0.96	0.00	1.28	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.32	3.46	3.14	4.71	5.03	3.14	1.89	0.94	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	4.94	8.46	5.64	4.23	0.00	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	8.41	8.41	4.49	4.49	0.56	1.68	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	0.80	9.55	4.78	5.57	1.59	3.18	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	2.72	7.47	1.70	6.12	1.02	2.04	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	9.10	5.52	5.20	3.57	0.97	2.60	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	12.42	9.58	9.58	5.32	9.23	1.06	1.77	2.13	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	7.90	7.90	15.79	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	9.75	5.85	3.41	14.14	0.49	0.49	3.41	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	7.93	7.93	3.97	14.88	0.00	0.00	3.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.04	5.63	3.75	2.35	14.07	0.47	1.41	4.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.94	6.29	6.29	3.31	9.60	0.99	0.99	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.32	8.97	7.73	2.78	7.42	0.62	1.55	2.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.76	9.48	6.11	6.11	11.01	0.31	0.92	2.45	0.00
Adipocyte - breast, donor1	11376-118A8	31.04	12.99	13.46	7.29	8.39	2.69	0.79	4.12	0.00
Adipocyte - breast, donor2	11327-117E4	14.12	11.23	13.48	12.03	9.14	1.93	1.28	2.73	1.44
Adipocyte - omental, donor1	11473-119C6	25.95	13.23	11.20	9.29	10.31	2.80	1.91	3.18	0.76
Adipocyte - omental, donor2	11474-119C7	15.70	3.74	11.21	6.73	8.97	0.75	0.75	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	27.13	10.38	14.74	8.37	9.38	2.68	1.67	1.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	8.93	4.47	6.38	3.19	12.12	1.28	0.00	3.19	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	9.90	11.00	9.90	5.50	0.00	1.10	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	15.36	9.03	14.45	6.32	14.00	4.06	1.81	5.42	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	6.78	7.82	8.17	4.69	6.08	4.17	0.87	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	44.98	13.69	18.97	16.04	5.08	5.87	3.72	1.96	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	6.69	9.52	9.01	4.12	3.86	1.54	1.03	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	11.99	24.25	14.22	5.58	4.74	3.07	1.95	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	8.23	21.75	14.11	8.23	5.29	5.88	1.18	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	34.75	16.49	18.26	15.93	5.63	6.19	2.73	2.73	1.29
Adipocyte differentiation, day08, donor2	13023-139D8	12.59	9.68	16.14	9.68	6.46	3.55	3.55	3.23	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	17.06	4.27	8.53	5.33	9.60	2.67	1.60	2.13	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.80	4.45	10.57	8.90	7.23	5.56	5.56	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	26.20	12.48	10.81	9.98	4.57	3.74	1.66	2.91	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	15.07	9.29	10.80	5.53	6.53	2.51	2.01	4.02	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	16.69	8.51	10.80	5.89	4.25	4.58	1.96	3.93	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	19.49	10.35	12.79	8.83	4.26	4.87	0.91	2.13	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	23.20	16.80	14.36	9.72	9.06	0.22	1.33	3.54	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	60.96	43.03	39.80	25.10	18.65	1.43	1.43	6.10	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	10.78	10.78	13.18	3.59	2.40	2.40	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	52.35	34.72	23.75	12.41	5.58	1.08	0.90	1.62	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	58.57	35.14	30.12	16.73	13.39	0.00	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	64.30	37.19	25.68	13.56	4.11	0.82	1.64	1.64	0.21
Anulus Pulposus Cell, donor1	11248-116E6	17.85	4.23	5.72	4.92	8.01	4.46	2.52	2.17	1.60
Anulus Pulposus Cell, donor2	11463-119B5	16.90	5.39	5.88	8.08	9.31	2.45	2.94	1.22	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	4.49	5.39	3.15	9.44	2.25	0.90	3.59	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.68	2.60	6.95	3.47	6.51	1.30	0.87	3.47	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	0.00	0.00	2.14	2.14	2.14	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.65	3.89	5.08	4.48	5.08	2.09	0.60	2.09	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	6.32	2.53	3.79	3.79	1.26	3.79	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	4.62	3.96	1.98	2.64	0.00	0.66	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	9.42	1.95	5.85	3.57	4.87	0.97	0.65	2.27	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.22	5.34	6.80	2.91	6.80	1.94	0.97	1.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	5.94	6.53	2.38	5.94	1.78	0.59	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.68	5.27	4.52	3.39	4.90	0.75	0.75	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	10.89	5.81	6.53	5.08	2.90	2.90	1.45	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	5.02	7.52	1.25	10.03	1.25	1.25	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.50	5.44	6.42	5.60	5.60	1.48	0.99	1.48	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	6.82	6.82	8.19	8.19	1.36	1.36	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.12	7.24	3.92	4.83	3.77	0.60	0.45	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	7.50	3.75	4.82	3.21	4.29	2.68	2.14	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.68	5.67	7.75	6.99	3.97	0.57	1.70	2.46	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.36	5.88	3.74	2.94	6.68	0.80	2.41	1.34	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	5.85	3.90	5.85	4.88	2.93	0.98	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.79	2.82	5.31	4.48	5.47	1.49	0.83	1.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	8.41	3.60	6.00	9.61	2.40	1.20	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	3.54	7.08	3.54	3.54	3.54	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.27	4.46	6.86	5.15	5.49	1.37	0.34	2.06	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	4.19	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	3.40	8.25	1.94	3.40	2.43	0.49	3.40	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.87	4.17	7.59	5.31	4.93	1.52	0.38	1.90	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	2.42	4.85	3.63	0.00	0.00	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	6.27	4.56	2.28	5.70	1.71	1.71	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.97	4.28	5.77	4.06	5.77	2.14	0.86	1.71	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	6.45	4.39	4.65	3.61	1.29	0.77	0.77	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.38	1.88	5.63	6.10	6.57	1.88	0.00	2.35	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.72	2.57	5.47	9.65	6.11	1.93	1.93	2.57	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	6.42	4.99	4.28	7.13	1.43	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	4.09	2.92	4.09	1.17	4.68	0.58	0.00	2.92	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.34	5.42	5.12	6.32	6.02	1.51	1.81	3.01	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	3.56	2.38	3.56	4.75	0.00	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	3.05	7.12	4.58	7.12	1.02	1.53	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	3.82	6.11	6.37	5.60	2.04	0.76	2.29	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	6.35	4.45	2.54	6.35	0.64	0.64	0.64	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.54	1.29	3.88	2.59	5.18	0.43	0.86	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.31	4.87	5.08	5.93	5.93	1.27	0.00	2.12	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.83	6.96	4.35	2.03	6.38	1.74	0.29	1.74	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	2.83	5.67	2.83	5.67	1.89	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.90	4.92	7.29	5.26	5.26	1.36	0.68	2.54	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	2.32	0.00	2.32	6.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	2.11	6.34	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.08	5.36	6.00	5.15	3.86	1.72	1.29	2.79	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	5.41	2.41	3.61	7.22	1.20	1.20	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	4.37	5.83	0.73	5.10	2.19	1.46	3.64	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.13	4.83	7.59	6.67	2.53	0.69	0.46	2.53	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	7.65	0.00	2.55	5.10	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	3.56	2.03	3.31	3.56	0.76	1.27	1.27	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.83	4.13	5.99	3.51	4.95	1.24	0.83	2.27	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	4.59	3.67	1.22	3.98	1.22	1.53	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	0.96	2.87	1.43	5.26	4.78	0.48	2.87	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	4.43	7.10	5.10	3.99	2.00	1.33	2.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	7.63	6.10	4.58	1.53	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	2.77	4.98	1.11	5.54	1.66	1.11	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	4.24	5.03	3.71	5.30	2.38	0.26	2.12	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	2.91	2.54	2.18	4.72	2.18	1.09	1.09	1.09
Astrocyte - cerebellum, donor1	11500-119F6	18.79	17.19	15.11	9.83	10.81	3.32	5.28	1.47	3.56
Astrocyte - cerebellum, donor2	11580-120F5	41.25	24.65	17.46	15.06	10.44	2.40	3.08	2.91	3.08
Astrocyte - cerebellum, donor3	11661-122F5	36.50	20.76	19.72	20.97	8.39	2.52	4.40	2.10	5.66
Astrocyte - cerebral cortex, donor1	11235-116D2	51.94	26.84	11.50	14.99	6.27	1.74	4.88	0.70	2.79
Astrocyte - cerebral cortex, donor2	11316-117D2	49.50	29.28	14.88	17.47	13.43	1.46	3.24	3.72	3.88
Astrocyte - cerebral cortex, donor3	11392-118C6	62.50	39.68	21.48	14.92	11.34	1.34	2.24	3.73	3.43
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	18.81	18.23	35.55	26.15	3.10	8.49	3.33	0.34	8.37
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	17.29	20.67	37.58	27.94	5.14	8.14	3.26	0.13	7.02
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.73	17.87	33.34	32.89	2.84	7.97	1.71	0.34	7.97
Basophils, donor1	12241-129G9	8.63	4.71	13.34	8.89	3.92	9.94	8.89	0.52	4.45
Basophils, donor2	12242-129H1	8.66	3.61	12.27	8.66	8.66	15.15	6.13	1.08	3.25
Basophils, donor3	12243-129H2	21.61	9.26	27.64	19.84	2.94	12.79	7.35	1.47	6.03
Bronchial Epithelial Cell, donor1	11511-119G8	40.53	14.45	10.56	10.56	5.61	0.00	0.65	1.08	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	72.69	37.49	20.57	18.29	14.17	0.91	0.91	2.29	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	35.87	14.35	7.17	0.00	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	69.67	33.27	25.11	17.57	13.18	0.63	0.63	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	63.01	30.15	18.92	17.05	12.48	2.50	1.25	3.33	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	33.16	15.89	16.12	11.05	5.07	1.61	0.46	0.92	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	7.92	8.10	9.72	6.30	1.80	0.36	1.80	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	46.58	21.23	47.92	31.43	0.00	1.75	5.36	0.00	4.84
Burkitt's lymphoma cell line:RAJI	10476-106I8	44.25	24.69	22.36	21.89	2.56	0.93	4.43	0.00	5.36
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	108.72	41.57	39.01	19.83	0.32	1.60	8.95	0.00	9.91
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34	31.03	0.00	0.00	0.00	10.34	0.00	51.71
CD14+ Monocytes, donor1	11224-116B9	10.71	4.51	16.91	11.83	1.13	13.53	2.25	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	11.88	6.87	20.42	13.55	3.16	14.29	5.38	0.93	5.01
CD14+ Monocytes, donor3	11381-118B4	14.05	7.90	21.51	15.37	2.41	14.05	7.68	1.10	5.49
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.66	10.19	24.62	11.04	11.32	3.40	4.25	5.66	1.98
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.85	19.71	21.99	14.78	15.16	3.41	6.07	3.41	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.68	16.11	32.55	12.16	7.23	7.23	3.94	4.27	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	10.41	6.22	13.01	11.13	3.04	12.72	8.96	0.87	4.05
CD14+ monocytes - mock treated, donor2	11873-125C1	12.07	6.34	9.05	8.75	6.94	7.54	3.62	2.11	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	12.08	5.92	12.32	12.32	6.63	12.56	4.50	3.32	3.79
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	8.04	3.85	6.53	4.18	1.84	5.19	2.18	0.50	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.00	3.04	4.42	3.86	4.42	4.69	1.38	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.69	3.97	4.71	5.45	3.97	5.21	1.49	1.74	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.27	2.55	7.24	5.09	1.96	2.74	1.96	0.00	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	10.33	5.34	6.41	4.27	3.20	2.49	1.07	1.60	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.22	1.31	3.70	4.79	6.09	1.96	1.31	1.96	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.38	3.04	4.68	3.51	1.17	6.09	0.94	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	6.34	6.86	4.75	2.64	7.92	2.64	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	0.00	6.66	7.77	3.33	2.22	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.26	4.46	8.63	5.80	3.27	10.11	3.27	0.59	1.78
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.38	4.79	5.59	5.59	5.59	9.18	2.39	2.39	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.58	2.08	2.91	3.33	7.50	3.75	1.87	1.67	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.55	4.12	6.86	3.89	0.69	2.52	1.14	0.46	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.46	2.94	3.62	5.20	2.71	3.85	1.13	0.90	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	3.93	3.49	3.49	2.18	2.18	0.44	1.31	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.53	5.92	8.07	6.19	4.03	6.19	2.15	1.61	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.00	6.98	8.72	6.11	5.58	4.01	1.57	2.97	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	7.57	5.05	6.31	8.00	10.10	5.05	5.47	2.10	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.78	2.39	2.39	2.39	0.37	0.73	0.73	0.37	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	1.76	3.52	3.52	0.70	2.82	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.63	1.75	1.75	2.19	2.63	1.75	0.00	0.88	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.54	4.01	5.58	4.88	1.39	4.71	1.57	0.35	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	5.95	4.09	6.32	4.09	5.95	1.49	1.12	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.76	4.74	6.47	4.74	3.02	3.88	2.59	1.51	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.55	3.28	5.73	6.14	2.05	2.87	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	1.85	2.32	2.09	0.70	2.78	0.70	0.46	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.26	1.62	2.09	1.86	2.32	2.09	0.23	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	7.19	3.92	8.50	3.92	5.23	6.76	4.58	0.22	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	15.94	6.47	12.01	7.62	4.16	10.86	9.70	1.62	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	7.58	3.90	5.20	5.42	3.47	3.25	3.25	0.87	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	14.79	7.79	25.69	14.01	2.80	12.46	9.65	1.56	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	11.00	6.11	19.56	10.65	3.84	15.02	8.73	0.17	3.49
CD14+CD16- Monocytes, donor3	11910-125G2	4.68	3.34	14.49	12.04	2.68	28.99	4.68	0.45	6.47
CD14-CD16+ Monocytes, donor1	11790-124B8	11.99	4.34	8.17	3.83	2.04	5.10	7.66	0.51	2.55
CD14-CD16+ Monocytes, donor2	11800-124C9	11.20	2.85	11.42	7.03	2.20	10.32	8.12	0.44	4.61
CD14-CD16+ Monocytes, donor3	11911-125G3	5.47	2.95	8.63	5.68	1.68	5.68	4.42	0.84	5.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	2.03	24.39	8.13	2.03	4.06	6.10	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	12.20	4.07	27.12	6.78	3.39	8.81	4.07	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	3.11	20.71	8.28	4.14	3.11	3.11	0.00	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	11.73	4.80	18.12	9.06	2.13	9.06	9.06	0.00	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.26	2.14	21.44	11.79	1.61	12.33	8.58	0.00	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	2.81	20.36	8.42	2.81	10.53	2.81	0.00	3.51
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	11.77	7.84	32.94	5.49	3.92	8.63	3.92	0.78	5.49
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	6.59	18.46	5.27	2.64	7.91	3.95	0.00	3.95
CD19+ B Cells, donor1	11544-120B5	16.44	9.86	28.77	13.97	1.64	23.01	7.40	0.00	5.75
CD19+ B Cells, donor2	11624-122B4	10.16	9.43	29.02	6.53	0.73	10.16	4.35	0.73	4.35
CD19+ B Cells, donor3	11705-123B4	9.59	7.57	21.71	5.05	1.51	12.12	4.54	0.00	8.08
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	68.69	38.39	31.52	39.60	3.64	19.39	17.78	0.81	21.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	67.91	39.55	32.76	36.75	1.60	11.59	10.79	0.80	9.19
CD34+ Progenitors, donor1	11545-120B6	21.09	10.04	5.02	2.01	1.00	0.00	2.01	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	24.16	3.37	9.55	6.74	4.49	0.56	10.11	0.00	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	92.06	44.71	24.42	18.04	0.38	1.13	7.52	0.38	7.14
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	81.40	27.51	24.80	11.73	1.58	1.35	6.76	0.45	8.34
CD4+ T Cells, donor1	11225-116C1	31.06	11.07	28.92	13.93	5.00	21.07	11.07	1.43	3.21
CD4+ T Cells, donor2	11306-117C1	36.13	13.47	28.78	11.02	9.19	19.60	10.41	0.61	7.35
CD4+ T Cells, donor3	11382-118B5	36.90	14.03	27.75	9.76	9.15	21.35	7.01	0.61	4.88
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	30.88	15.06	27.31	11.23	31.14	14.29	5.62	4.59	3.32
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	43.35	18.42	35.04	22.01	29.65	17.52	5.39	3.14	3.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.36	19.83	43.12	17.82	27.88	19.83	4.31	2.30	3.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.33	8.06	19.91	5.69	9.48	9.96	11.85	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	17.56	8.43	21.77	5.62	16.15	9.13	14.05	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	6.59	13.18	3.30	9.89	16.48	23.07	0.00	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.16	9.54	21.82	13.15	17.92	13.44	5.64	2.46	3.76
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	49.31	24.40	37.96	19.15	26.10	12.88	6.27	3.22	2.88
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.18	18.54	30.79	14.35	17.89	12.09	4.67	1.13	2.58
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	21.97	10.31	13.90	3.59	13.45	10.76	5.38	1.34	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.75	10.48	26.90	7.69	15.02	10.83	10.48	1.05	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	17.60	4.84	12.76	11.00	17.16	16.72	8.80	1.32	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	35.84	14.34	24.03	12.65	23.19	11.38	8.01	5.48	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	49.45	21.40	33.24	26.80	14.75	9.56	4.99	1.25	3.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	45.44	20.72	31.41	18.38	14.03	7.02	8.02	1.34	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	37.53	13.60	28.83	8.97	16.32	17.13	14.14	1.09	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	10.72	29.48	7.50	19.83	24.12	12.33	1.61	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	10.76	28.69	12.55	16.14	26.90	19.73	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	59.71	21.32	40.98	20.77	17.99	11.87	3.71	2.04	3.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	59.14	23.18	36.18	24.26	13.86	9.75	4.33	3.25	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	63.68	30.26	53.59	36.36	10.30	17.65	6.94	1.05	3.36
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	33.37	5.06	24.27	7.58	16.18	11.12	7.58	2.53	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	32.49	7.37	26.43	6.93	20.36	9.10	11.26	3.47	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	22.66	9.15	20.05	9.15	21.35	22.23	7.84	1.74	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	36.13	7.42	36.13	17.32	44.54	13.86	19.30	4.45	3.96
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	16.62	9.23	20.31	6.46	42.47	9.23	17.54	1.85	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	9.77	18.15	8.37	57.23	4.19	8.37	1.40	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.02	9.14	40.43	14.40	32.40	14.95	21.05	2.77	5.82
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	27.24	7.12	42.21	11.78	43.43	21.35	20.61	1.96	5.15
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	7.70	29.26	10.78	50.82	9.24	7.70	3.08	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.01	8.95	35.45	15.04	46.91	15.04	13.97	3.94	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	26.31	2.77	34.62	16.62	45.70	5.54	13.85	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	33.07	11.13	37.65	17.02	17.02	16.37	10.48	1.96	5.89
CD8+ T Cells, donor2	11307-117C2	21.78	9.01	25.53	12.39	11.64	7.51	9.39	1.13	7.51
CD8+ T Cells, donor3	11383-118B6	36.61	16.92	38.13	18.68	12.88	14.39	12.37	1.77	10.10
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.16	14.22	6.19	5.73	58.04	2.75	1.61	7.34	2.75
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	11.26	13.42	8.87	4.31	55.84	2.88	1.20	7.43	3.35
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.22	9.58	5.47	4.10	41.31	1.37	3.01	6.29	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.40	2.10	4.80	2.40	64.55	1.50	3.00	15.31	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.28	9.36	4.80	5.04	70.07	0.72	2.64	9.12	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.82	10.69	7.50	6.14	55.25	3.18	3.41	6.37	4.32
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.78	12.60	10.21	3.26	61.06	1.96	0.87	11.30	2.39
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	15.00	7.63	3.68	62.12	2.63	1.58	8.16	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.48	16.18	6.57	3.99	58.63	1.41	0.47	9.62	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.00	17.51	8.75	4.53	60.68	3.02	2.72	7.55	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.92	19.17	8.42	5.52	53.45	0.00	0.58	7.26	3.20
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	20.52	23.71	7.73	3.46	65.28	1.60	1.07	10.39	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.57	7.44	8.76	6.13	34.14	3.06	2.19	3.50	3.50
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	7.29	7.29	6.38	36.89	2.73	2.73	3.64	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	14.92	7.46	7.46	35.06	1.49	0.75	0.75	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	11.52	8.28	4.32	73.11	1.44	2.16	6.84	3.96
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	11.51	14.96	4.89	6.62	75.67	3.45	2.30	8.92	2.59
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.61	13.91	6.84	5.89	54.45	1.65	2.12	10.37	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.61	10.46	8.87	1.90	73.84	3.80	1.58	12.68	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.15	18.45	5.54	4.61	73.82	2.15	0.62	10.15	3.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	12.18	7.37	2.89	57.06	1.92	0.64	6.41	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.59	18.36	6.88	2.29	48.19	1.53	2.68	8.03	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.37	11.82	9.06	3.15	54.39	4.34	0.79	6.70	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	13.62	16.64	4.54	3.78	46.90	2.27	0.76	4.54	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	11.24	7.23	5.62	61.83	7.23	3.21	3.21	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.89	10.49	13.29	8.39	58.05	6.29	3.50	9.79	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	9.02	13.02	8.01	69.12	12.02	3.01	6.01	6.01
Cardiac Myocyte, donor1	11525-119I4	36.55	12.79	10.97	14.62	12.79	0.00	7.31	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	33.60	14.33	7.91	12.35	7.41	1.98	1.48	3.46	1.48
Cardiac Myocyte, donor3	11686-122I3	24.62	10.00	12.63	9.05	7.37	1.16	0.53	1.79	0.84
Chondrocyte - de diff, donor1	11261-116G1	45.76	16.64	17.68	7.97	18.72	2.77	1.73	4.85	1.04
Chondrocyte - de diff, donor2	11338-117F6	17.06	5.33	11.37	9.60	12.08	2.49	0.36	3.91	0.71
Chondrocyte - de diff, donor3	11410-118E6	31.29	11.38	15.36	8.53	14.34	2.84	2.16	4.78	1.02
Chondrocyte - re diff, donor2	11339-117F7	13.43	8.06	2.69	1.79	16.11	3.58	0.00	9.85	1.79
Chondrocyte - re diff, donor3	11411-118E7	25.07	14.15	16.98	11.73	19.82	4.85	2.43	5.66	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	25.02	12.74	8.72	7.34	10.10	1.03	3.90	2.41	3.21
Ciliary Epithelial Cells, donor2	11323-117D9	14.75	12.83	7.70	7.48	10.26	1.92	1.71	3.42	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	25.04	18.05	9.03	10.44	10.35	0.97	1.59	3.89	4.60
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.46	14.12	16.96	9.90	7.52	6.88	5.41	2.66	3.94
Corneal Epithelial Cells, donor1	11526-119I5	19.32	14.05	12.52	7.69	4.17	1.10	0.22	1.32	0.66
Corneal Epithelial Cells, donor2	11606-120I4	17.06	14.79	3.41	5.69	3.41	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.22	12.78	12.53	7.16	2.30	2.56	0.51	1.28	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.58	8.09	12.05	8.25	13.70	2.15	1.49	4.95	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	7.57	7.25	15.46	7.89	12.30	1.89	1.26	5.99	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	6.90	17.25	6.90	13.80	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.56	7.56	11.23	9.61	13.28	1.30	1.30	6.70	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.37	12.30	24.26	13.32	3.42	5.81	3.76	1.02	5.47
Dendritic Cells - plasmacytoid, donor2	11309-117C4	8.49	1.96	16.32	12.40	3.26	3.92	4.57	0.00	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	5.81	24.20	7.74	1.94	4.84	6.78	0.97	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	38.19	11.84	14.68	10.84	11.51	2.17	1.33	6.84	1.67
Endothelial Cells - Aortic, donor1	11263-116G3	33.45	15.26	19.95	14.08	14.08	2.93	1.17	5.28	4.69
Endothelial Cells - Aortic, donor2	11340-117F8	24.32	12.73	21.21	11.03	10.75	3.68	1.41	5.09	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	37.75	15.33	16.12	11.40	13.37	1.97	2.36	5.50	1.57
Endothelial Cells - Artery, donor1	11264-116G4	35.49	15.42	15.42	10.47	11.05	2.33	1.16	6.98	1.45
Endothelial Cells - Artery, donor2	11341-117F9	48.00	22.59	23.29	17.88	16.47	2.35	1.88	7.53	1.88
Endothelial Cells - Artery, donor3	11413-118E9	40.50	19.99	19.81	13.32	13.50	2.10	1.05	8.59	1.58
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.74	6.65	10.86	9.75	3.55	3.32	1.99	1.11	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.91	7.30	7.30	6.39	2.13	2.13	0.91	0.61	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	5.64	5.07	11.28	5.36	2.82	3.10	1.13	1.13	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	20.50	3.86	12.18	12.78	4.16	2.08	0.89	0.59	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	7.29	4.69	5.21	8.33	7.81	0.52	0.52	5.21	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.22	11.48	16.31	11.06	2.69	2.69	1.56	1.70	2.84
Endothelial Cells - Thoracic, donor1	11266-116G6	26.01	12.80	13.60	14.80	11.20	2.80	1.20	1.60	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	13.63	17.82	14.15	8.91	0.52	1.57	3.14	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.49	20.38	19.13	16.15	3.85	3.11	2.98	1.99	2.36
Endothelial Cells - Umbilical vein, donor2	11324-117E1	47.36	24.77	18.68	19.77	4.78	3.69	3.48	2.17	5.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	57.28	28.82	17.59	16.85	6.23	3.79	1.47	3.30	4.03
Endothelial Cells - Vein, donor1	11267-116G7	72.80	27.30	36.40	17.06	7.96	3.41	0.00	3.41	3.41
Endothelial Cells - Vein, donor2	11344-117G3	43.31	30.04	20.96	11.87	13.97	2.79	2.79	6.29	2.10
Endothelial Cells - Vein, donor3	11416-118F3	43.96	20.57	20.72	17.11	8.48	1.10	1.73	5.65	2.83
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	6.60	8.25	8.25	13.20	3.30	16.50	8.25	0.00	1.65
Eosinophils, donor3	12246-129H5	3.57	7.13	7.13	7.13	0.00	21.40	7.13	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	23.94	18.08	9.53	9.77	9.28	1.22	0.24	3.18	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	12.48	10.40	6.24	0.00	0.00	2.08	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	11.49	6.57	6.16	5.34	4.93	1.64	5.34	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.34	2.96	3.72	2.41	4.16	0.44	1.20	1.20	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	40.09	16.58	14.08	6.61	7.69	0.98	0.87	2.06	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	29.35	12.01	12.86	8.85	6.55	1.21	0.97	4.37	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4.50	1.23	2.73	3.00	2.59	5.73	2.18	1.64	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.77	8.75	11.39	6.86	6.75	2.11	1.58	2.74	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.43	4.48	6.06	3.69	2.63	5.27	2.11	1.05	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.85	22.59	14.62	8.97	8.64	2.66	1.00	3.99	2.33
Fibroblast - Cardiac, donor1	11268-116G8	32.66	12.70	15.88	9.98	13.61	2.72	1.81	4.54	1.81
Fibroblast - Cardiac, donor2	11345-117G4	31.83	21.22	20.46	6.82	21.98	1.52	0.76	8.34	0.76
Fibroblast - Cardiac, donor3	11417-118F4	40.22	19.56	18.61	14.35	21.13	2.05	0.95	8.36	1.73
Fibroblast - Cardiac, donor4	11452-119A3	31.22	16.67	15.16	13.64	6.67	4.55	1.52	4.55	1.82
Fibroblast - Cardiac, donor5	11456-119A7	39.97	18.02	14.72	11.68	8.12	1.90	1.27	3.43	1.02
Fibroblast - Cardiac, donor6	11460-119B2	47.15	17.28	13.19	10.76	9.10	1.21	1.36	4.70	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	9.51	5.49	9.92	8.04	7.77	4.02	3.35	3.08	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.65	5.61	9.49	5.61	10.35	3.45	0.43	3.45	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	17.58	19.04	14.65	14.65	0.00	1.46	2.93	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	20.99	18.22	18.68	17.99	3.69	8.07	2.54	1.15	3.46
Fibroblast - Conjunctival, donor3	11692-122I9	48.00	15.26	16.11	11.53	9.16	7.12	3.22	2.20	3.05
Fibroblast - Dermal, donor1	11269-116G9	13.62	4.23	5.40	7.51	6.81	1.41	1.17	2.35	1.17
Fibroblast - Dermal, donor2	11346-117G5	12.26	11.79	8.49	7.55	7.55	2.83	0.47	3.30	1.42
Fibroblast - Dermal, donor3	11418-118F5	18.37	9.31	9.31	7.37	7.86	1.45	0.60	2.66	1.33
Fibroblast - Dermal, donor4	11450-119A1	21.93	13.57	11.76	8.25	3.50	2.03	2.26	1.24	2.03
Fibroblast - Dermal, donor5	11454-119A5	23.90	16.22	16.75	9.94	3.66	1.40	1.57	1.22	1.57
Fibroblast - Dermal, donor6	11458-119A9	23.55	19.00	13.16	6.82	3.90	1.62	1.30	1.79	1.46
Fibroblast - Gingival, donor1	11237-116D4	14.99	5.83	7.50	7.29	7.29	2.29	1.46	4.16	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	49.26	18.34	10.48	10.22	11.79	2.88	2.36	2.36	1.31
Fibroblast - Gingival, donor2	11318-117D4	29.26	15.02	11.60	11.33	7.25	1.71	0.92	2.64	2.50
Fibroblast - Gingival, donor3	11394-118C8	23.88	9.57	12.28	11.80	9.19	7.06	2.03	5.41	1.93
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	43.63	12.47	16.62	13.51	6.23	2.08	4.16	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.77	15.68	17.80	10.22	7.93	1.06	3.35	3.35	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.35	19.02	13.56	8.57	8.26	2.18	0.62	2.49	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.59	13.25	7.17	4.73	4.46	2.43	1.89	2.84	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	129.51	61.05	44.82	28.23	13.06	8.47	2.12	5.65	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	66.54	24.72	12.72	8.19	13.31	2.49	1.46	3.80	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	31.63	11.59	8.73	4.91	11.59	3.14	0.95	4.36	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	73.49	36.42	17.77	10.31	10.53	2.85	1.54	4.83	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	33.75	14.53	13.94	6.31	9.39	4.99	3.52	2.79	0.59
Fibroblast - Lung, donor1	11270-116H1	42.14	14.95	16.31	16.31	4.08	0.00	1.36	1.36	4.08
Fibroblast - Lung, donor2	11347-117G6	31.34	16.41	13.43	13.43	4.48	7.46	1.49	1.49	5.97
Fibroblast - Lung, donor3	11419-118F6	55.08	25.11	21.31	17.09	7.60	3.17	2.32	2.74	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	28.32	8.33	16.66	10.00	22.49	9.16	0.83	5.83	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	8.39	9.79	5.59	5.59	4.20	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.79	11.20	11.75	12.03	10.92	3.92	1.12	3.64	0.00
Fibroblast - Mammary, donor1	11540-120B1	38.57	24.36	17.05	13.80	13.40	4.47	2.03	5.28	1.62
Fibroblast - Mammary, donor2	11620-122A9	39.94	35.95	3.99	19.97	19.97	3.99	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00	5.96	11.91	0.00	17.87	0.00	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.20	19.20	15.71	9.12	6.60	1.75	2.13	1.16	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.86	18.51	14.71	10.47	7.43	2.88	2.43	3.19	3.94
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.08	7.96	7.96	6.43	7.04	4.28	0.61	4.90	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.22	17.94	14.88	12.59	11.07	1.53	1.53	6.11	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.11	12.42	11.07	8.10	10.80	1.35	2.16	3.78	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	36.07	16.82	19.72	12.99	8.93	3.60	1.39	2.67	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	36.48	19.45	15.36	8.62	19.56	0.88	1.33	7.07	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.74	17.07	14.02	13.00	7.92	4.47	1.02	3.66	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	19.38	18.04	10.69	10.02	6.01	2.00	4.68	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.51	9.88	9.88	6.33	5.93	1.19	1.98	3.16	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.55	3.37	5.16	4.56	5.36	4.37	4.17	1.59	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.87	5.68	10.30	7.82	6.22	2.84	1.78	2.84	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.63	9.46	10.84	10.45	15.18	1.97	1.97	3.35	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.83	3.61	7.52	6.62	8.72	2.71	3.01	3.01	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.35	5.07	10.90	8.53	13.60	3.78	2.59	3.35	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.56	1.52	5.06	4.30	5.82	7.85	4.05	2.02	2.02
Fibroblast - skin normal, donor1	11553-120C5	21.82	8.53	9.52	8.53	10.01	3.12	1.97	3.77	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	17.24	7.22	4.81	4.21	8.82	7.62	1.60	3.21	2.21
Fibroblast - skin normal, donor2	11561-120D4	19.29	8.04	11.65	7.94	13.46	1.61	1.61	3.52	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	7.25	4.53	6.95	3.02	6.04	4.53	3.32	1.51	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.95	9.03	14.42	8.86	8.20	4.56	1.99	2.65	1.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.24	4.27	9.74	5.64	9.92	7.01	2.05	3.42	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.55	4.27	5.91	4.27	9.85	6.24	2.63	2.63	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.20	8.63	8.42	5.43	11.93	2.77	1.81	6.39	1.60
Fibroblast - skin walker warburg, donor1	11554-120C6	31.04	16.53	8.94	8.27	11.98	2.53	0.84	4.89	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	18.03	3.29	8.31	3.92	10.82	1.57	1.57	6.74	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	12.20	11.33	14.82	1.74	4.36	1.74	3.49	3.49	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.68	10.23	8.49	7.11	1.39	1.56	0.69	0.87	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.44	8.85	10.15	8.07	2.86	1.56	0.52	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.33	14.31	8.43	9.20	2.04	1.28	0.51	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	72.73	46.70	40.57	23.73	5.36	0.77	12.25	0.77	6.89
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	52.96	31.27	24.25	19.14	5.10	0.00	10.85	0.64	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	33.09	17.40	25.39	27.67	3.42	3.42	19.68	1.14	15.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	131.26	93.76	31.16	41.64	2.48	3.86	35.57	0.00	28.40
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	92.70	58.22	30.14	25.80	2.97	2.05	25.80	0.91	12.56
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	68.95	38.64	39.63	40.62	3.17	5.15	17.24	0.79	20.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	137.45	94.10	30.13	39.91	1.06	3.97	39.39	0.00	29.87
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	108.61	69.47	28.70	37.83	3.26	3.26	22.18	1.30	16.31
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.63	19.46	26.53	17.69	2.21	1.33	11.94	0.88	15.04
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	30.53	24.59	18.51	21.76	2.69	1.84	10.88	0.57	9.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.34	35.46	19.33	19.70	5.79	2.09	8.74	0.49	6.53
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	29.28	25.52	18.00	19.34	3.22	0.54	6.45	0.27	6.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.90	29.24	25.27	26.51	8.92	0.37	5.70	2.60	4.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.04	26.44	20.90	25.47	7.20	1.25	7.34	1.52	6.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.70	17.48	13.62	15.65	5.90	2.03	4.68	1.42	6.10
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.16	26.01	21.68	22.36	7.53	2.51	5.93	2.51	5.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.00	29.65	15.82	19.18	5.85	1.00	5.36	1.49	2.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.94	33.66	21.42	28.41	3.93	1.53	4.15	0.87	8.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	43.14	31.62	30.14	27.78	7.39	1.18	10.93	1.18	7.68
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.88	31.95	18.92	22.57	4.61	1.27	9.38	1.59	4.61
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	45.13	32.84	21.90	27.70	3.80	1.79	6.93	1.12	7.15
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.60	27.62	28.63	26.62	3.23	1.81	9.07	0.81	6.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.00	28.16	20.36	20.02	5.43	1.70	11.54	1.19	5.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.20	33.07	22.35	25.36	8.34	1.60	6.38	1.86	4.97
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	82.52	48.28	38.60	30.18	5.93	3.95	19.25	0.73	8.12
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.65	35.01	27.49	21.86	6.49	2.39	19.98	0.85	6.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	51.90	30.76	23.13	23.24	5.53	1.66	12.17	0.89	5.64
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.00	29.45	18.89	21.30	9.23	2.25	9.23	3.33	6.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.06	21.64	13.68	17.56	11.23	1.63	10.82	3.06	3.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	46.21	27.44	23.31	28.26	5.78	2.06	10.52	1.65	8.05
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	50.73	29.52	18.56	23.17	4.61	1.27	13.72	0.92	6.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.86	24.35	21.51	18.68	7.84	1.17	10.84	0.83	5.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	55.55	33.95	24.91	21.16	8.16	2.65	14.77	0.44	5.51
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	50.92	29.03	18.57	17.71	8.98	1.23	10.95	0.74	4.06
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.69	31.61	24.64	21.88	8.27	1.46	6.00	2.11	7.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.71	33.03	19.56	16.36	8.02	2.25	15.39	0.96	5.45
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.99	30.70	20.56	20.85	6.82	1.23	9.85	1.52	4.45
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	44.92	31.00	19.14	18.98	7.28	1.58	8.86	0.95	3.01
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.27	27.06	20.37	20.68	10.03	2.13	9.73	0.61	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.19	23.83	19.44	19.13	9.41	1.57	6.69	0.84	3.66
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	50.94	28.32	18.66	15.81	9.66	1.32	7.68	2.63	3.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	45.73	28.90	20.48	18.52	9.82	1.96	6.73	1.68	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.90	25.65	15.74	11.76	6.57	1.76	4.91	1.57	2.04
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.76	25.40	13.90	12.03	7.22	0.53	4.01	2.14	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	41.92	23.72	13.16	15.76	8.72	1.38	1.84	0.61	1.99
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	41.45	23.71	14.51	12.05	7.38	1.55	3.37	1.94	2.33
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	65.06	27.38	14.10	12.20	8.40	1.36	3.80	2.44	3.25
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.41	22.12	20.46	15.85	7.93	2.95	6.27	1.66	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	40.13	23.47	17.98	13.38	8.11	4.17	6.36	1.75	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	97.19	37.69	13.88	15.87	6.94	6.94	6.94	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.14	22.95	17.54	15.96	7.12	2.64	3.43	1.85	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.20	21.39	19.17	14.12	9.68	3.03	3.23	2.02	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	68.37	34.31	12.71	11.69	10.67	12.45	7.12	2.54	3.81
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.72	12.34	17.72	19.11	1.39	2.19	7.37	0.00	7.76
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	27.43	28.35	23.11	22.50	1.85	1.23	9.55	1.08	9.55
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	24.75	23.53	15.55	19.64	1.43	2.25	8.80	0.20	11.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.47	20.97	15.65	14.08	1.25	0.31	8.14	0.31	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	20.91	21.76	11.02	13.00	2.26	0.00	3.96	0.00	4.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.46	11.99	6.46	9.22	0.46	0.00	2.77	0.92	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	19.80	27.22	19.80	2.47	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	23.60	19.34	14.31	12.76	1.16	0.39	6.19	0.39	6.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	22.46	20.86	9.63	1.60	1.60	4.81	0.00	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	24.34	17.39	10.43	3.48	0.00	10.43	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.55	17.58	16.92	15.62	1.30	0.65	5.21	0.00	4.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.88	17.71	14.41	11.53	0.82	0.82	9.47	0.00	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	19.99	33.32	19.99	0.00	3.33	23.33	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.41	19.85	16.22	16.22	1.12	0.28	6.99	0.28	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.11	19.94	16.34	17.32	1.96	1.63	5.88	0.00	6.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.91	36.07	22.65	21.81	3.36	0.84	9.23	1.68	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.35	25.76	21.95	24.49	1.27	0.64	9.22	0.00	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	23.44	22.08	16.30	17.66	3.74	0.34	6.45	0.34	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	35.50	16.71	8.35	0.00	0.00	6.26	2.09	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.21	20.62	18.90	22.34	2.86	1.15	11.45	0.00	9.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	37.29	23.68	14.21	19.83	1.18	0.89	7.99	0.00	6.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	42.35	35.58	11.86	15.25	0.00	0.00	5.08	0.00	10.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	38.11	23.20	14.50	19.47	3.31	0.00	4.14	0.41	6.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	47.87	31.07	19.56	18.87	2.07	0.46	8.28	0.92	5.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	36.88	15.81	26.34	5.27	0.00	10.54	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.83	19.61	12.69	8.46	2.31	0.00	8.46	0.38	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.99	21.84	8.15	14.67	2.28	0.00	5.22	0.98	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	29.43	21.40	17.39	2.01	0.67	7.36	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.08	19.26	18.88	24.66	2.31	0.39	12.33	0.77	6.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	57.17	23.62	22.59	23.62	3.42	0.68	5.48	0.68	6.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	32.30	27.33	22.36	0.00	0.00	12.42	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.15	29.73	17.93	25.95	1.89	0.00	13.21	0.47	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	50.09	23.54	22.33	21.73	4.83	1.81	10.86	0.00	6.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	51.88	33.06	22.38	16.79	2.54	1.02	11.70	1.02	9.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.47	31.11	21.14	25.53	1.99	0.80	11.57	1.20	5.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	37.99	18.25	14.31	18.75	1.97	0.00	6.41	0.49	3.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	38.95	21.25	14.17	8.26	5.90	1.18	9.44	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	25.09	13.42	21.59	3.50	1.17	8.17	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.15	29.84	15.80	14.48	3.07	0.88	13.61	0.00	5.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	12.72	11.87	14.41	2.54	0.85	5.93	0.00	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.86	16.71	5.97	11.34	3.58	0.60	8.36	1.19	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.00	14.56	9.70	15.53	2.43	1.46	5.82	0.49	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	9.13	5.71	12.55	6.85	1.14	2.28	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.72	7.90	11.23	5.41	11.64	5.41	0.83	4.16	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	40.48	33.73	26.99	21.36	14.62	5.62	3.37	5.62	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.88	1.59	4.76	5.71	5.39	3.17	2.54	1.90	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	3.76	4.18	3.34	7.94	1.67	2.09	2.51	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	63.71	38.64	9.98	7.08	7.77	2.67	0.46	1.97	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.45	31.90	8.78	7.43	5.23	2.03	0.00	1.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	38.68	32.08	10.24	5.92	5.46	3.19	0.23	0.91	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.28	32.90	13.34	6.56	5.68	2.62	0.44	1.75	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	52.22	33.74	10.96	7.74	5.16	3.22	0.64	1.72	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	34.23	23.47	8.61	4.74	7.32	1.51	0.86	1.29	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.63	35.00	12.83	7.47	4.73	1.87	0.62	1.25	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	41.86	26.42	7.89	5.15	6.35	2.06	0.34	1.03	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	36.52	28.19	9.93	7.69	3.52	2.88	0.32	1.28	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	53.16	24.62	29.10	19.59	5.04	2.80	4.48	1.12	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	34.62	22.51	21.21	13.42	12.98	0.00	2.60	4.76	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	15.86	10.58	10.58	15.86	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	54.67	39.86	17.28	18.34	10.58	2.12	1.41	3.53	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	54.49	25.43	20.34	13.08	13.80	1.45	2.91	2.91	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.74	18.18	7.87	11.01	11.19	0.70	1.22	5.94	0.87
Hepatocyte, donor1	11523-119I2	4.84	2.42	7.26	8.47	0.00	2.42	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	17.24	8.62	18.31	17.24	1.08	8.62	4.31	0.00	1.08
Hepatocyte, donor3	11684-122I1	6.75	4.91	17.18	14.11	1.84	4.29	3.68	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	102.47	54.83	29.37	18.28	9.14	0.00	6.53	0.65	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.54	15.73	9.61	6.99	2.80	0.70	1.40	1.05	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	6.86	6.59	4.80	7.27	1.23	1.23	1.92	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	50.94	35.02	9.55	41.39	0.00	0.00	12.74	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	60.08	33.38	6.68	20.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00	27.08	0.00	0.00	81.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	71.99	33.23	18.00	8.31	38.76	5.54	0.00	5.54	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	50.05	17.52	15.02	27.53	7.51	0.00	12.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	71.21	35.60	35.60	118.68	0.00	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	61.51	35.88	7.69	30.75	15.38	2.56	5.13	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	18.28	13.71	4.57	18.28	0.00	0.00	4.57	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	81.22	43.86	29.24	19.49	53.60	1.62	0.00	8.12	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	65.02	40.02	11.67	8.34	48.35	8.34	1.67	10.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	29.04	21.78	7.26	21.78	7.26	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	74.11	45.00	25.15	10.59	46.32	7.94	2.65	17.21	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	58.76	41.02	21.06	12.20	37.69	5.54	1.11	6.65	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	20.95	20.95	5.24	26.19	10.48	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	84.40	46.61	13.86	8.82	38.42	6.30	1.26	10.08	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	52.59	21.65	20.11	44.85	3.09	0.00	9.28	4.64
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	43.90	29.27	0.00	14.63	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	103.37	62.02	20.03	7.75	32.95	7.75	1.94	10.98	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	75.67	80.50	20.93	11.27	41.86	4.83	0.00	12.88	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	71.69	11.95	11.95	47.79	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	101.04	75.78	24.45	12.22	39.11	4.89	3.26	13.04	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	91.10	57.51	20.99	15.11	41.14	5.04	1.26	19.31	4.20
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	14.37	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	97.25	42.60	22.50	10.45	39.38	4.82	0.80	12.06	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	37.85	21.24	12.00	24.93	4.62	0.92	11.08	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	30.16	0.00	15.08	0.00	15.08	0.00	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	86.38	60.42	17.47	10.86	35.40	1.89	0.47	14.16	3.78
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	56.23	44.44	14.51	10.88	39.91	6.35	1.81	12.70	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48	14.74	0.00	29.48	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	93.62	64.57	22.60	9.69	31.21	4.30	2.15	9.69	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	90.20	43.20	25.41	10.16	49.55	5.08	0.00	8.89	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	65.72	16.43	0.00	49.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	99.48	53.57	29.97	11.48	36.99	7.65	0.00	7.01	6.38
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	38.28	12.76	9.11	40.10	9.11	0.00	10.94	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	47.41	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	89.97	57.13	20.71	12.85	27.13	7.85	0.00	5.00	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	86.28	29.86	29.86	6.64	53.09	3.32	0.00	13.27	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	83.39	0.00	0.00	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	76.86	52.78	14.82	8.64	35.50	3.40	0.31	8.95	3.70
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	77.26	40.39	17.56	10.54	42.14	7.02	0.00	12.29	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	37.72	12.57	15.72	37.72	18.86	0.00	9.43	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	80.67	63.28	20.17	17.38	27.82	4.87	2.78	8.34	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	137.21	68.61	50.90	24.34	42.05	11.07	0.00	6.64	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	94.02	48.63	38.90	9.73	19.45	0.00	6.48	6.48	16.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	114.22	82.83	34.01	20.93	22.67	12.21	0.87	3.49	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	103.49	49.50	58.49	22.50	20.25	9.00	4.50	4.50	18.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	83.63	69.69	48.78	13.94	10.45	10.45	3.48	6.97	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	130.15	72.54	33.07	14.93	24.54	14.93	1.07	5.33	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	87.28	44.33	38.79	18.01	48.49	20.78	2.77	4.16	5.54
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	74.09	65.54	25.65	5.70	42.74	5.70	0.00	11.40	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	102.17	70.87	22.09	12.89	34.98	7.36	1.84	8.28	8.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	69.58	48.41	66.56	18.15	6.05	18.15	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	111.76	68.30	37.25	37.25	12.42	6.21	0.00	6.21	18.63
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	117.37	58.16	63.44	16.92	12.69	8.46	0.00	0.00	6.34
Keratinocyte - epidermal, donor1	11272-116H3	15.42	10.93	7.59	6.61	4.90	1.80	0.57	1.31	0.57
Keratinocyte - epidermal, donor2	11349-117G8	20.50	15.81	11.71	6.44	2.34	0.59	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	17.98	14.96	8.71	8.99	1.70	1.42	0.38	0.76	0.57
Keratinocyte - oral, donor1	11251-116E9	24.18	12.94	10.22	8.97	7.04	2.16	0.91	2.16	0.34
Keratocytes, donor1	11527-119I6	18.57	14.10	20.63	13.75	8.94	2.75	1.38	2.75	1.38
Keratocytes, donor2	11607-120I5	26.95	17.58	12.89	8.20	9.37	1.17	3.52	3.52	2.34
Keratocytes, donor3	11688-122I5	18.18	13.83	26.28	15.81	6.52	2.96	1.98	0.79	2.37
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	13.19	19.78	19.78	4.40	24.18	0.00	0.00	8.79
Lens Epithelial Cells, donor1	11529-119I8	9.71	5.39	6.47	8.63	6.47	1.08	0.00	4.31	3.24
Lens Epithelial Cells, donor2	11609-120I7	22.72	11.65	14.53	11.30	6.80	2.19	5.42	2.19	2.42
Lens Epithelial Cells, donor3	11690-122I7	21.59	11.00	9.08	8.58	10.49	2.02	1.61	2.52	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.19	6.64	11.98	8.66	4.74	1.54	0.95	1.54	1.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.79	7.54	9.21	4.19	5.02	1.40	1.67	0.84	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.75	5.67	7.87	8.66	3.31	1.89	1.42	0.79	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	12.91	7.53	6.99	5.38	1.08	1.08	1.08	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.69	11.66	14.81	10.72	2.52	1.58	0.32	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	15.85	6.79	11.43	5.39	2.70	1.73	1.73	1.08	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	4.92	7.80	5.34	2.87	0.82	1.64	0.82	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	21.24	12.14	14.16	9.10	2.53	0.76	0.76	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.92	6.05	9.71	7.46	4.08	1.27	0.70	0.42	1.69
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	4.35	7.52	3.56	3.56	2.37	1.19	0.40	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	16.67	8.53	12.02	7.56	2.91	1.94	1.94	0.97	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	15.92	6.48	9.26	6.30	4.07	0.37	1.30	0.93	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.24	6.27	7.32	5.23	2.44	1.05	0.35	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.65	9.30	8.83	8.35	4.05	2.15	0.95	0.48	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.76	7.42	10.71	6.46	4.53	1.10	2.06	0.69	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	4.00	8.93	4.00	4.00	1.23	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.09	7.17	9.04	7.79	2.18	1.56	1.25	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.19	6.77	10.61	7.32	5.31	1.10	1.10	1.46	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.86	4.94	8.89	6.91	3.95	1.65	0.66	1.32	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.06	8.79	10.54	9.96	3.22	1.76	1.46	1.17	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.69	6.22	6.97	7.22	4.73	0.75	1.74	1.74	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	5.33	11.15	5.82	6.30	0.48	0.00	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.00	7.54	7.00	5.12	2.15	1.35	0.27	0.27	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.74	8.78	8.48	6.81	3.63	1.36	1.51	1.21	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	2.59	4.67	1.04	1.56	2.07	1.04	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	13.82	10.05	9.42	7.75	1.68	1.47	0.63	0.84	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.29	7.52	10.83	9.17	3.16	1.05	1.05	1.65	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.82	2.75	8.94	4.82	7.57	1.38	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.13	8.28	9.22	6.77	2.45	0.94	1.13	0.94	1.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	15.69	6.26	9.22	6.04	4.88	1.27	1.59	0.95	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	10.18	3.88	12.11	3.88	3.39	0.48	0.00	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	10.92	9.26	4.30	2.98	2.32	1.98	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.24	7.81	12.51	7.68	5.95	1.24	0.87	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	11.11	4.44	8.89	5.55	3.70	0.74	1.11	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.81	5.44	7.17	3.71	2.22	1.98	0.99	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.30	7.42	9.49	9.62	3.99	1.37	1.51	1.10	1.51
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	3.86	9.97	5.15	4.18	0.32	1.61	1.29	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.13	8.52	5.48	6.39	4.26	3.96	1.22	1.22	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.56	5.60	10.78	8.96	3.92	1.26	1.26	0.42	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	7.47	7.82	4.98	6.40	1.07	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	9.21	10.67	4.85	1.45	3.88	1.94	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.21	7.62	11.67	8.25	5.29	1.09	1.87	1.09	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	9.31	5.73	8.24	5.01	4.66	1.43	1.79	1.07	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	20.25	9.80	10.13	5.88	3.59	2.29	0.98	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.48	5.65	9.18	6.59	5.65	1.18	2.35	0.94	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	13.86	8.42	12.38	9.03	4.83	0.87	0.74	1.98	0.99
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	19.72	9.48	12.81	5.63	2.56	2.82	1.02	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.32	5.67	11.34	7.76	6.27	1.79	1.19	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	90.64	36.26	38.52	9.06	22.66	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	87.45	51.40	41.43	28.38	21.48	2.30	3.07	10.74	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.06	39.34	30.43	28.95	25.24	2.23	1.48	8.16	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	71.51	44.43	38.08	22.43	25.81	2.96	3.39	9.73	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	107.61	53.45	43.61	30.24	21.10	4.22	2.81	11.25	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	79.39	44.83	30.82	27.09	28.95	2.80	0.93	16.81	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	54.10	29.89	21.13	11.85	30.92	2.58	4.64	5.15	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	103.48	61.85	38.06	27.36	22.60	1.19	2.38	7.14	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	114.00	60.62	38.91	21.04	23.07	2.94	2.26	12.44	2.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	59.04	37.81	20.07	11.92	20.07	1.45	2.33	8.43	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	76.98	43.67	31.06	16.66	19.81	0.45	1.80	10.80	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	144.02	66.79	49.72	26.01	27.77	2.98	3.79	12.60	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	90.38	50.33	40.57	18.49	26.70	5.65	2.05	14.38	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	88.57	43.05	31.40	23.64	24.70	0.71	1.06	11.64	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	59.30	33.98	19.99	8.66	31.32	2.67	0.67	8.66	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	78.45	53.49	32.60	20.88	21.39	3.57	1.53	9.68	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	94.72	44.29	28.55	20.54	22.14	1.60	2.13	9.61	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	78.79	46.10	22.67	19.65	24.18	3.02	2.65	12.66	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	84.67	53.38	31.91	22.09	29.45	2.45	3.68	9.82	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	100.30	53.00	46.48	29.36	28.54	0.82	2.45	9.79	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	87.25	40.19	21.03	16.24	23.32	2.08	2.29	11.04	3.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	70.35	37.27	26.91	15.41	25.22	1.40	2.52	9.53	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	100.97	54.61	50.49	40.18	31.94	4.12	2.06	11.33	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	86.51	46.16	25.26	20.61	24.39	2.03	1.45	11.32	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	66.66	29.89	25.41	14.05	21.82	0.60	1.20	9.86	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	86.31	45.92	27.66	18.81	19.36	1.11	0.00	12.72	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	97.56	60.09	33.58	26.51	21.21	4.24	3.53	9.19	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	68.59	44.99	25.81	19.55	21.39	1.84	1.84	9.59	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	80.59	37.99	27.63	27.63	17.27	2.30	2.30	14.97	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	84.04	47.20	34.54	22.64	33.39	2.30	3.84	13.05	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	55.48	42.46	27.17	14.72	23.78	2.83	3.96	10.76	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	77.94	54.15	38.56	19.69	38.56	2.46	1.64	12.31	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	84.50	59.65	26.21	21.69	28.92	3.62	0.90	13.10	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	54.58	34.47	24.42	17.24	25.85	2.15	3.59	9.34	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	112.78	62.74	41.08	28.38	38.84	2.24	3.73	11.20	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	100.33	40.88	30.47	24.15	27.87	1.49	2.60	10.40	3.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	49.11	34.03	22.40	13.35	27.14	2.58	1.72	8.18	3.45
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	86.49	32.54	41.10	21.41	28.26	1.71	0.86	12.84	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	103.28	49.98	32.65	23.32	30.99	3.00	0.67	13.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	56.71	43.44	34.39	25.34	27.75	1.21	1.21	11.46	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	93.14	46.21	46.21	31.28	31.28	2.84	2.13	14.22	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	95.21	52.93	36.43	28.87	27.84	1.72	0.34	12.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	47.23	48.84	27.37	19.32	39.72	3.22	2.15	12.35	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	80.13	44.44	33.67	23.57	37.03	3.37	2.69	14.81	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	94.08	60.75	25.19	29.26	33.34	4.44	3.33	12.96	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	84.89	22.10	31.40	13.96	33.72	0.00	2.33	15.12	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	88.85	46.54	39.14	19.04	32.79	1.06	0.00	16.92	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	93.24	56.82	36.41	26.01	28.01	4.80	3.20	16.01	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	61.06	45.07	32.71	18.17	16.72	0.00	4.36	10.18	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	112.68	52.12	43.69	32.19	29.89	2.30	6.13	13.80	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	99.64	61.17	38.48	24.66	33.54	3.45	2.96	11.84	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	41.40	32.93	32.93	14.11	19.76	0.94	0.94	8.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	121.18	57.32	43.75	37.21	31.68	6.03	2.51	11.56	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	98.24	45.51	35.15	22.98	28.84	6.76	4.06	12.17	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	55.08	29.26	18.93	10.33	22.37	3.44	0.00	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	114.01	56.11	39.64	30.28	24.94	5.34	3.12	12.91	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	93.06	58.26	27.37	19.55	25.03	2.74	2.74	10.95	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	52.12	35.63	27.05	17.81	19.79	1.98	3.30	6.60	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	102.23	57.08	37.88	26.98	29.58	3.63	4.67	11.94	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	80.95	29.75	25.82	18.38	28.88	3.94	3.50	11.38	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.35	30.19	26.28	17.89	25.16	2.24	2.80	7.83	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	89.21	47.26	32.24	28.27	29.59	1.32	1.32	15.90	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	101.44	48.21	26.61	21.99	26.61	3.09	3.47	8.87	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	58.23	34.94	32.91	11.65	25.32	1.01	4.05	7.60	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	76.90	50.95	34.12	25.47	25.47	2.88	0.48	10.09	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	80.30	38.96	29.02	26.24	32.20	3.58	2.78	13.12	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	58.33	34.63	26.13	18.23	27.34	0.61	3.65	6.08	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	67.10	29.74	22.83	16.60	30.43	0.00	1.38	4.15	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	95.38	45.98	30.78	25.84	34.20	3.80	2.28	13.68	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	37.18	37.18	14.98	26.85	3.61	3.61	11.88	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	74.98	30.23	44.74	20.56	27.21	1.81	3.02	7.26	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	85.88	42.46	32.96	23.77	38.35	2.85	3.17	13.63	2.22
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	51.71	45.85	27.72	14.93	35.72	4.26	2.13	11.19	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	70.11	21.26	39.08	17.24	33.91	4.02	2.30	11.49	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	96.16	44.74	29.31	24.68	40.62	1.54	4.11	14.40	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	53.05	36.08	21.22	22.64	31.12	3.54	0.71	15.56	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	67.53	34.05	48.24	21.56	40.29	2.84	2.27	17.59	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	91.94	55.33	41.19	23.30	39.52	3.74	3.33	19.14	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	39.94	28.19	14.88	11.75	42.28	2.35	3.13	17.23	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	71.40	25.05	40.08	23.38	40.92	2.92	2.51	12.11	2.51
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	105.47	40.42	31.60	21.37	32.99	1.39	3.72	11.62	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	45.50	37.47	22.08	11.37	38.80	1.34	5.35	14.05	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	74.32	35.82	32.08	23.52	50.79	3.21	3.74	14.97	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	80.01	36.37	30.31	14.55	44.45	0.40	1.21	22.63	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	58.74	44.05	32.12	19.27	45.89	1.84	1.84	16.52	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	75.57	28.45	32.90	17.78	51.57	1.78	0.00	8.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	87.76	46.73	32.48	31.34	53.00	4.56	1.14	21.09	3.99
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	47.55	47.55	27.61	16.10	63.65	2.30	3.83	19.17	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	72.77	32.83	34.47	12.59	64.57	2.74	3.83	20.25	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	91.32	48.55	36.53	26.28	63.25	0.89	0.89	16.04	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	112.30	59.53	37.43	24.70	74.87	1.82	3.12	30.93	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.30	23.87	47.08	33.16	80.90	0.66	0.66	20.56	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	128.87	72.75	51.97	31.18	93.54	12.47	4.16	24.94	2.08
Macrophage - monocyte derived, donor1	11232-116C8	9.80	7.07	18.46	7.07	5.24	1.60	2.51	3.42	0.68
Macrophage - monocyte derived, donor2	11313-117C8	5.14	5.87	6.06	5.87	5.87	0.92	1.65	2.75	1.47
Macrophage - monocyte derived, donor3	11389-118C3	10.49	11.01	13.37	9.70	5.90	1.84	1.57	1.97	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	6.37	3.72	3.19	1.06	0.00	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	5.23	5.23	5.39	4.12	1.58	0.32	0.32	0.63	0.48
Mallassez-derived cells, donor3	11930-125I4	9.59	4.73	5.14	4.45	2.78	1.25	0.14	0.42	0.83
Mammary Epithelial Cell, donor1	11273-116H4	23.32	16.04	11.66	4.88	1.79	5.38	1.00	0.70	1.20
Mammary Epithelial Cell, donor2	11350-117G9	14.77	10.13	7.24	4.34	3.19	1.74	0.58	1.45	0.29
Mammary Epithelial Cell, donor3	11422-118F9	28.93	16.71	12.72	13.22	1.50	2.99	0.75	1.25	1.00
Mast cell - stimulated, donor1	11487-119E2	2.03	0.68	0.00	0.00	13.56	3.39	1.36	2.03	3.39
Mast cell, donor1	11563-120D6	54.50	25.30	32.12	15.79	22.28	4.87	9.08	7.89	5.41
Mast cell, donor2	11565-120D8	43.39	33.88	30.01	10.70	19.32	23.48	19.61	7.43	2.67
Mast cell, donor3	11566-120D9	43.67	37.82	37.37	13.51	16.66	24.99	18.91	4.95	2.70
Mast cell, donor4	11567-120E1	49.11	41.13	32.27	10.64	19.86	19.50	22.87	6.56	4.79
Mast cell, expanded and stimulated, donor5	11940-126A5	12.64	9.09	21.40	11.98	23.51	21.29	6.32	4.44	4.44
Mast cell, expanded and stimulated, donor8	11942-126A7	18.09	19.26	14.01	6.42	33.27	6.42	15.18	4.09	5.25
Mast cell, expanded, donor5	11939-126A4	27.30	18.58	38.09	13.31	33.04	7.11	8.37	5.97	2.64
Mast cell, expanded, donor8	11941-126A6	59.75	35.82	44.18	20.59	31.13	13.22	16.90	4.85	5.36
Melanocyte - dark, donor1	11502-119F8	38.01	16.32	27.86	22.88	2.89	1.29	1.79	1.29	2.19
Melanocyte - dark, donor2	11582-120F7	31.84	13.50	9.69	8.31	7.61	0.35	0.69	2.42	2.42
Melanocyte - dark, donor3	11663-122F7	23.25	15.43	8.48	8.33	24.20	2.39	3.48	5.94	1.96
Melanocyte - light, donor1	11274-116H5	32.91	18.57	19.98	11.05	14.34	4.00	1.18	7.05	1.18
Melanocyte - light, donor2	11351-117H1	51.87	29.35	18.43	12.28	12.28	2.05	2.05	2.05	2.05
Melanocyte - light, donor3	11423-118G1	39.03	20.81	13.01	12.14	16.48	1.73	3.47	3.47	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	22.91	16.14	14.89	10.10	27.38	1.46	2.19	8.64	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	24.20	13.18	7.53	4.30	19.63	1.08	1.61	4.30	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	37.23	13.12	14.20	11.79	24.11	1.07	1.61	5.62	0.80
Meningeal Cells, donor1	11493-119E8	8.56	7.32	12.53	5.71	7.82	2.61	2.85	2.61	2.85
Meningeal Cells, donor2	11573-120E7	12.76	6.60	14.97	4.84	7.48	4.84	2.64	4.84	6.16
Meningeal Cells, donor3	11654-122E7	11.25	7.58	9.70	4.97	9.13	1.47	1.39	3.99	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	36.21	12.26	6.56	6.84	11.98	0.57	1.43	2.28	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.99	6.24	6.64	6.74	4.53	1.71	0.70	1.51	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	68.34	31.54	42.05	17.08	14.46	17.08	3.94	10.51	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	14.39	9.16	5.23	6.54	3.92	2.62	2.62	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	34.45	21.53	10.76	7.18	15.79	3.59	2.15	2.87	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.85	8.05	11.22	13.13	8.89	2.12	1.48	2.54	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	10.05	10.56	5.53	4.02	3.02	1.01	2.51	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.05	18.24	8.57	6.81	14.72	1.54	1.32	6.37	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	22.65	24.84	8.04	8.04	10.23	2.19	0.73	2.19	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	35.19	18.41	11.05	6.75	17.19	1.23	1.23	5.32	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.79	4.85	7.76	4.29	8.86	2.63	1.52	2.91	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	32.71	13.01	15.24	17.47	16.73	4.83	1.86	6.32	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.89	10.39	8.95	8.68	10.79	1.97	1.58	3.55	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	44.81	13.95	9.50	10.39	14.54	8.01	1.78	5.04	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	32.70	18.68	7.01	7.01	11.68	9.34	0.00	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	40.35	18.57	17.29	10.89	7.04	1.28	1.92	3.84	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.38	20.56	13.47	10.28	23.04	0.71	0.71	6.38	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	8.76	8.76	5.00	10.32	0.94	0.31	5.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	18.14	7.98	5.08	5.81	1.45	0.73	3.63	1.45
Mesothelial Cells, donor1	11247-116E5	5.04	1.86	9.28	5.30	2.39	2.12	1.33	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	9.51	3.50	5.00	8.01	4.50	1.00	1.50	2.00	0.50
Mesothelial Cells, donor3	11402-118D7	9.25	9.25	9.68	7.52	6.29	1.23	0.65	1.52	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	13.50	6.75	9.45	4.05	9.45	0.00	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.84	7.88	8.87	4.68	10.84	2.71	2.71	2.96	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.72	10.01	7.66	8.54	11.19	1.18	2.06	3.53	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	24.20	10.37	6.91	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.61	6.20	7.13	6.20	6.82	1.86	1.86	2.17	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	8.50	7.05	4.15	5.81	10.58	0.41	1.24	4.36	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	13.90	9.26	4.63	6.95	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.01	5.51	9.76	12.76	12.51	2.25	2.25	6.51	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	10.71	9.78	2.79	7.91	14.90	1.86	1.86	2.79	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	19.47	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.35	6.10	9.55	7.72	10.57	3.25	2.64	3.45	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.27	9.11	9.90	3.17	10.30	0.79	1.19	4.36	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	2.65	7.08	5.31	8.85	0.88	1.77	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	8.36	4.56	6.46	10.64	0.00	1.52	6.84	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	6.58	2.63	2.63	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.76	3.82	6.37	3.82	7.64	1.06	0.21	2.97	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	6.45	4.60	5.52	3.68	0.00	0.00	3.68	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	6.86	9.24	4.17	5.07	0.60	0.00	2.68	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	6.71	0.00	5.03	6.71	0.00	0.00	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	3.01	5.02	5.77	8.03	0.25	0.50	2.26	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.42	6.18	2.85	4.75	6.18	0.24	0.24	3.09	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	3.87	4.98	3.87	2.21	1.11	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.14	2.76	2.76	4.14	6.45	0.46	0.00	3.68	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.94	2.94	3.16	3.58	12.41	0.42	0.42	2.94	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.48	3.06	2.24	2.45	4.69	0.41	0.20	1.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.86	4.93	2.79	3.00	5.58	0.64	0.64	3.22	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	5.56	2.89	2.89	6.45	0.67	0.44	1.33	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	10.32	10.32	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	1.97	1.97	3.50	4.60	0.22	0.22	2.41	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	3.55	3.55	5.07	3.04	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	3.31	0.00	0.00	4.97	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.81	1.90	3.53	3.26	3.81	0.27	0.00	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.71	3.23	2.35	1.47	5.00	0.00	0.00	3.23	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	2.18	2.18	1.09	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	4.81	2.88	2.88	4.32	5.29	0.00	0.00	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.20	1.20	1.20	1.60	1.60	1.60	0.00	2.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	0.00	1.37	5.48	0.00	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	4.00	2.50	4.51	2.50	4.00	0.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2.19	2.63	1.31	0.44	3.07	0.44	0.00	2.19	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	6.62	2.21	0.00	3.31	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.92	1.28	2.56	1.92	1.92	0.64	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.23	1.74	0.25	1.24	3.97	0.50	0.50	2.48	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	1.39	0.00	0.00	2.78	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	4.42	2.21	0.00	2.21	0.00	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.37	1.37	1.37	1.37	5.47	1.71	0.34	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	1.31	1.75	0.00	4.38	0.88	0.44	2.19	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.42	1.78	2.49	2.84	2.13	5.68	0.71	1.42	1.78
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	1.12	0.56	0.56	1.40	4.21	1.12	1.12	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.25	1.66	0.00	0.42	7.07	0.42	0.42	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	2.33	2.91	5.24	1.75	1.75	0.00	0.58	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.30	1.21	3.02	1.81	5.13	0.60	0.90	0.60	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2.50	2.09	0.83	1.67	8.77	0.00	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	7.22	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2.77	0.92	0.92	0.92	3.69	0.00	0.00	0.92	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.85	3.41	1.71	1.71	5.69	1.14	0.57	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.04	3.45	3.87	1.93	2.76	1.24	0.69	0.97	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1.81	1.30	1.04	1.55	4.15	0.26	0.52	1.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	4.29	1.72	2.14	8.15	2.14	0.43	0.86	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	4.45	3.18	4.45	5.08	3.18	1.27	1.27	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.80	0.80	2.40	1.87	3.20	0.80	1.07	0.27	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.29	0.90	1.20	2.39	10.78	3.29	0.30	4.19	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.54	2.54	4.10	3.96	2.26	1.84	0.71	0.99	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.96	0.32	1.59	1.27	4.46	0.32	1.27	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2.87	1.77	0.88	3.54	7.74	0.88	0.88	2.21	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.03	4.17	3.03	2.65	2.65	3.03	0.76	1.14	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1.42	1.42	2.56	1.42	3.98	0.28	0.85	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	2.46	1.97	1.97	4.92	7.13	0.98	1.23	3.69	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	1.30	0.65	4.56	4.56	2.61	1.30	0.65	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.88	2.06	1.47	3.53	5.29	2.65	1.18	1.47	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.04	2.02	1.15	3.46	10.67	2.59	1.44	2.59	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1.65	2.06	4.95	4.12	2.89	4.53	1.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1.19	1.79	0.60	2.98	6.25	0.89	1.19	1.49	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	3.77	7.53	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	8.91	7.13	7.13	12.48	0.00	3.56	5.35	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.81	12.81	14.79	11.83	10.19	2.63	2.96	4.27	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	7.36	15.78	8.42	9.47	2.10	0.00	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.69	16.61	13.84	6.33	8.90	0.99	2.37	4.55	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	30.73	19.56	14.90	4.66	9.31	2.79	0.93	3.73	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.65	10.14	9.01	5.26	4.88	1.88	2.63	3.00	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.17	12.52	8.52	7.99	7.99	0.80	1.60	2.66	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.82	5.99	8.26	5.43	10.07	1.36	1.36	3.05	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.05	16.94	9.58	8.84	6.63	2.21	2.21	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.79	10.99	9.89	9.53	6.60	2.20	1.83	5.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	7.78	9.33	1.56	7.78	1.56	3.11	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.14	1.07	1.07	1.60	6.95	0.53	0.00	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	3.86	7.73	19.32	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	22.22	20.20	9.09	9.09	13.13	1.01	3.03	4.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.37	4.64	2.53	1.69	4.22	0.42	0.84	2.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	1.36	4.09	0.00	0.00	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	0.00	0.00	1.51	1.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	5.71	39.97	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	3.26	0.00	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	4.75	0.00	4.75	4.75	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.05	12.28	13.36	7.32	13.36	0.65	0.86	4.74	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	35.02	17.77	20.38	9.41	13.59	2.09	2.09	2.61	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	40.05	28.03	8.01	6.01	3.34	3.34	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	53.01	11.69	13.77	6.68	0.42	1.25	0.42	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	48.68	15.78	10.08	6.46	6.08	2.66	4.94	0.76	2.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	31.92	12.77	15.96	3.19	4.79	0.00	0.00	6.38
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	17.00	3.40	1.36	2.04	3.40	1.36	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	18.38	7.35	3.68	9.19	1.84	0.00	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	37.67	12.97	7.53	5.44	1.67	1.67	0.84	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	41.14	13.71	6.28	5.11	1.63	1.63	2.09	0.46	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	71.88	23.24	16.21	10.54	4.05	1.62	1.35	1.35	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	36.79	14.93	12.61	11.35	4.41	3.57	2.31	1.68	2.73
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	11.13	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.28	6.95	3.97	2.48	2.98	0.99	0.99	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	33.02	3.52	7.58	4.33	2.98	3.25	2.71	0.00	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.21	5.89	3.85	4.08	1.81	1.13	2.49	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	53.40	14.53	15.19	9.63	2.45	2.61	2.94	0.49	2.45
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.87	13.12	14.58	10.94	2.55	4.74	2.37	0.73	2.19
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	9.55	7.96	3.18	2.12	1.59	1.59	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	29.41	9.60	8.40	5.40	1.80	2.40	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	3.28	5.91	3.28	1.97	8.86	6.24	0.66	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	35.94	6.67	5.69	4.72	1.30	1.30	1.63	0.00	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.22	12.88	16.58	10.58	3.00	6.88	1.23	0.53	2.12
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	32.35	10.55	2.81	6.33	0.70	1.41	2.81	0.00	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	39.53	13.79	5.52	2.76	1.84	3.68	2.76	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	35.03	13.82	9.96	7.71	3.86	2.25	2.57	0.64	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.31	4.83	7.59	6.21	1.72	5.17	4.83	1.03	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	0.00	45.51	12.64	5.06	32.87	0.00	0.00	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.17	14.04	12.03	12.70	4.23	5.79	0.89	0.67	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	37.68	9.74	7.20	8.04	2.12	2.96	1.69	0.42	3.81
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	31.09	8.31	6.88	2.85	2.14	1.66	1.66	0.00	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.06	17.60	6.01	4.29	4.72	1.72	3.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	36.32	19.33	17.66	9.33	2.67	2.67	1.33	0.00	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.99	16.68	15.33	9.92	3.61	4.06	0.00	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.63	10.71	8.73	1.59	1.98	0.79	2.38	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.93	11.14	13.93	10.22	2.79	0.93	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.08	7.19	7.19	3.41	7.19	1.51	2.65	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.35	13.69	8.80	11.73	2.61	2.93	1.30	0.65	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	52.73	14.82	9.59	12.20	3.49	2.18	3.49	0.87	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.07	8.59	10.85	10.40	7.24	4.52	1.81	0.90	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	13.23	8.82	9.70	2.65	1.76	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	17.95	10.64	2.66	1.99	1.33	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	29.27	16.37	5.46	5.46	4.96	1.98	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	40.20	14.16	13.78	3.83	2.68	1.15	1.91	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.71	5.75	7.26	6.05	2.12	2.42	5.14	0.60	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.69	11.05	14.59	8.62	3.09	3.09	3.32	0.44	2.21
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.85	9.49	14.23	4.74	2.03	2.71	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	15.33	10.22	5.11	15.33	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.17	12.19	10.36	9.75	5.49	1.22	3.66	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	44.38	12.90	13.22	5.98	3.46	0.94	1.57	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.62	16.65	13.32	8.17	1.82	3.33	4.54	0.00	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	4.75	10.28	3.96	1.58	2.37	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	3.40	22.67	6.80	5.67	9.07	5.67	0.00	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	15.17	0.00	5.06	10.12	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	20.25	6.34	4.60	4.22	10.44	1.61	0.37	3.23	0.37
Myoblast, donor2	11322-117D8	23.78	10.16	10.36	9.59	9.40	3.45	1.15	2.49	1.73
Myoblast, donor3	11398-118D3	17.66	9.92	9.25	4.88	6.05	2.69	0.50	2.52	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	28.75	13.86	25.10	21.45	5.98	6.28	2.19	1.02	4.52
Natural Killer Cells, donor1	11230-116C6	32.29	11.69	32.60	15.07	10.46	16.91	15.07	1.23	4.61
Natural Killer Cells, donor2	11311-117C6	33.77	12.67	29.55	18.39	10.86	13.27	8.14	0.60	8.75
Natural Killer Cells, donor3	11387-118C1	25.03	14.91	31.84	21.53	10.86	16.38	9.57	1.10	9.57
Neural stem cells, donor1	11275-116H6	21.05	21.05	28.31	19.96	7.62	8.35	5.81	2.18	7.26
Neural stem cells, donor2	11352-117H2	36.59	25.03	21.18	13.48	9.63	5.78	5.78	0.00	3.85
Neurons, donor1	11494-119E9	39.83	36.41	33.00	15.93	33.00	2.28	17.07	11.38	9.10
Neurons, donor2	11574-120E8	44.91	40.73	76.62	35.01	11.89	2.64	16.73	4.62	12.11
Neurons, donor3	11655-122E8	92.08	54.26	38.64	18.91	23.84	4.11	12.33	4.93	6.58
Neutrophils, donor1	11233-116C9	11.14	3.71	18.56	17.63	1.86	38.98	8.35	0.00	3.71
Neutrophils, donor2	11314-117C9	5.80	5.80	40.58	20.29	0.00	26.09	14.49	0.00	11.60
Neutrophils, donor3	11390-118C4	5.50	4.28	6.72	17.10	1.22	43.98	11.61	0.00	6.11
Nucleus Pulposus Cell, donor1	11252-116F1	16.03	5.11	9.14	7.96	6.77	6.53	3.21	2.26	2.02
Nucleus Pulposus Cell, donor2	11409-118E5	25.72	7.16	6.19	9.12	6.19	5.54	3.91	0.98	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	17.25	5.41	10.63	7.22	4.81	3.01	1.20	1.60	1.40
Olfactory epithelial cells, donor1	11933-125I7	34.28	13.90	16.11	13.08	6.06	2.62	2.48	1.38	1.65
Olfactory epithelial cells, donor2	11934-125I8	42.27	18.24	12.59	11.29	6.22	3.33	2.03	3.47	1.45
Olfactory epithelial cells, donor3	11935-125I9	37.23	15.66	14.98	10.78	4.65	2.50	1.14	1.59	1.02
Olfactory epithelial cells, donor4	11936-126A1	38.47	18.21	23.96	14.03	8.77	2.63	0.88	2.05	1.56
Oligodendrocyte - precursors, donor1	11496-119F2	30.09	10.83	15.05	12.04	3.61	1.81	0.60	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	42.75	15.10	15.53	13.40	12.55	5.96	3.40	3.62	2.13
Osteoblast - differentiated, donor2	11353-117H3	68.59	20.58	12.57	8.00	18.29	0.00	2.29	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	87.52	22.97	18.00	16.76	11.17	10.55	3.10	0.62	3.72
Osteoblast, donor1	11277-116H8	107.49	47.49	27.17	22.87	19.54	2.93	2.74	8.99	2.74
Osteoblast, donor2	11354-117H4	54.08	30.90	16.15	12.64	21.07	1.40	2.11	4.92	1.40
Osteoblast, donor3	11426-118G4	63.81	28.61	24.17	15.64	21.15	1.60	0.89	6.58	0.71
Pancreatic stromal cells, donor1	11249-116E7	16.34	7.58	6.99	5.22	5.81	3.37	1.35	2.27	0.67
Pericytes, donor1	11491-119E6	15.13	9.35	12.46	7.23	19.69	5.90	7.79	4.56	4.01
Pericytes, donor2	11571-120E5	29.88	12.22	16.52	12.45	20.60	6.11	8.38	5.89	5.66
Pericytes, donor3	11652-122E5	25.63	15.87	12.00	9.36	13.02	1.63	1.22	4.07	1.63
Perineurial Cells, donor1	11499-119F5	11.75	9.15	9.49	7.46	10.85	1.92	1.58	2.71	2.03
Perineurial Cells, donor2	11579-120F4	44.17	15.92	9.75	10.86	5.06	1.66	1.01	3.59	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	22.31	14.98	41.75	14.98	4.78	29.32	13.39	0.00	5.42
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.90	9.79	21.06	13.71	5.39	14.45	9.55	1.22	4.90
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.88	12.81	29.25	18.38	10.48	16.31	12.04	1.16	7.89
Placental Epithelial Cells, donor1	11278-116H9	59.79	40.18	27.50	15.55	7.17	0.48	2.87	3.11	1.20
Placental Epithelial Cells, donor2	11355-117H5	64.32	32.16	29.94	27.72	4.44	2.22	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	86.38	48.49	38.09	32.59	6.48	3.14	1.96	1.96	2.55
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	31.01	16.14	16.77	10.76	5.70	1.58	0.63	1.58	0.95
Preadipocyte - breast, donor1	11467-119B9	29.45	16.32	12.01	6.94	6.57	3.56	0.56	1.50	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.09	6.00	6.00	4.57	2.09	5.61	1.17	0.91	1.17
Preadipocyte - breast, donor2	11328-117E5	33.55	21.16	15.08	12.16	9.68	2.03	1.58	1.58	1.35
Preadipocyte - omental, donor1	11468-119C1	30.48	18.11	12.57	7.25	8.63	1.92	0.64	1.92	0.53
Preadipocyte - omental, donor2	11329-117E6	22.26	8.29	9.60	7.86	10.48	3.06	1.31	3.93	0.00
Preadipocyte - omental, donor3	11403-118D8	33.52	22.92	16.90	14.47	10.46	4.30	0.57	4.15	1.00
Preadipocyte - perirenal, donor1	11469-119C2	23.62	3.94	9.84	9.84	8.86	2.95	0.98	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.68	22.11	13.51	10.75	17.51	3.99	2.15	9.52	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	35.95	20.90	11.33	11.51	17.35	2.30	1.42	6.73	2.30
Preadipocyte - subcutaneous, donor3	11428-118G6	31.84	20.09	12.60	12.43	15.84	2.04	2.21	4.77	1.19
Preadipocyte - visceral, donor1	11280-116I2	35.49	19.47	13.88	7.45	8.38	3.91	1.02	4.66	0.84
Preadipocyte - visceral, donor2	11357-117H7	17.03	8.74	10.12	9.66	7.82	1.38	0.46	3.22	0.00
Preadipocyte - visceral, donor3	11429-118G7	32.60	17.55	11.28	9.61	6.90	2.09	1.46	1.88	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	84.02	35.30	12.52	6.18	1.66	0.00	2.11	0.91	1.36
Prostate Epithelial Cells, donor2	11331-117E8	6.23	7.18	5.42	5.01	4.47	0.95	0.54	1.35	0.41
Prostate Epithelial Cells, donor3	11404-118D9	16.17	10.96	17.51	17.15	1.04	0.61	0.37	0.31	0.80
Prostate Stromal Cells, donor1	11254-116F3	20.39	9.80	8.31	4.78	6.15	1.37	0.34	3.19	0.80
Prostate Stromal Cells, donor2	11332-117E9	16.14	12.91	10.76	6.81	9.68	1.26	1.08	4.12	0.90
Prostate Stromal Cells, donor3	11405-118E1	17.52	6.78	6.88	6.88	8.34	2.09	0.83	2.71	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.61	23.72	17.52	20.44	4.38	1.09	0.73	0.36	3.28
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.22	10.47	8.11	7.21	5.54	0.90	1.25	1.32	0.76
Renal Epithelial Cells, donor1	11517-119H5	78.62	63.40	24.85	25.87	16.74	1.01	2.54	4.57	3.55
Renal Epithelial Cells, donor2	11597-120H4	40.55	24.90	17.07	14.23	9.25	1.42	4.27	0.71	2.85
Renal Epithelial Cells, donor3	11678-122H4	24.45	14.93	11.86	10.90	5.19	1.69	1.59	1.91	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	43.57	13.62	21.79	17.70	7.49	0.00	0.68	0.68	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	42.59	14.29	15.63	13.48	7.68	1.89	1.75	2.29	1.89
Renal Glomerular Endothelial Cells, donor3	11675-122H1	35.74	24.64	16.43	14.43	12.21	1.33	2.00	3.11	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.25	27.28	42.59	22.63	10.65	3.33	2.66	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	50.62	29.05	16.29	12.10	17.61	1.54	1.10	4.84	1.32
Renal Mesangial Cells, donor2	11598-120H5	59.56	31.35	25.71	13.79	10.03	1.88	1.88	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	74.62	38.56	20.53	14.98	10.82	0.55	2.22	2.77	3.88
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.60	22.28	13.69	13.15	6.98	1.07	0.81	1.34	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.55	13.07	10.54	10.12	4.64	0.42	0.42	1.69	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	54.00	29.51	17.93	11.38	9.06	0.58	1.16	1.35	1.35
Retinal Pigment Epithelial Cells, donor0	11215-116A9	54.71	14.52	12.70	9.33	11.93	1.30	3.11	4.93	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	49.46	18.76	13.64	10.52	2.84	0.85	3.41	1.71	3.70
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	33.96	13.38	9.26	20.58	2.06	1.03	6.17	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.35	8.78	10.79	5.77	3.76	1.00	2.76	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	15.50	12.83	22.85	15.37	2.27	9.22	2.81	1.20	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	30.38	3.57	21.44	6.25	11.61	2.68	1.79	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.20	3.85	6.05	0.00	8.26	2.75	2.75	2.75	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	8.70	3.48	5.80	2.90	9.28	4.64	1.74	2.32	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.18	7.02	16.38	7.67	10.79	2.99	1.43	2.60	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.62	17.38	26.91	14.20	14.00	2.09	1.49	2.98	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.96	14.83	18.40	12.38	13.94	1.12	0.67	4.35	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	11.04	5.21	15.63	9.92	16.00	1.86	2.36	3.35	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.49	17.02	25.76	14.57	14.34	1.63	1.28	4.20	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	11.33	13.87	21.26	13.87	15.02	2.08	1.85	4.62	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.38	8.90	26.97	14.10	13.01	2.60	1.51	2.05	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.49	13.92	21.78	10.29	13.61	2.27	1.36	3.93	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.14	13.80	20.79	12.01	15.05	2.51	1.25	3.40	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.92	9.47	30.70	14.49	12.48	1.86	1.72	1.86	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.78	15.56	23.93	13.95	12.77	2.79	1.40	3.43	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.46	20.36	21.68	13.50	18.37	1.33	0.89	4.65	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.00	8.60	31.93	13.00	14.15	2.29	0.76	4.59	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.10	15.74	28.14	13.32	14.91	1.96	1.21	2.70	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	13.15	10.71	18.04	6.76	12.59	1.88	1.50	3.95	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	18.45	9.55	38.88	16.72	15.53	3.32	1.86	2.26	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.14	15.96	25.41	14.41	14.89	2.63	1.85	2.63	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.67	14.70	22.15	11.84	15.28	2.67	1.15	3.82	4.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.94	9.72	29.47	13.03	13.46	1.82	1.39	3.10	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	18.22	12.33	25.79	10.93	16.82	0.56	2.24	1.96	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.94	15.21	20.17	11.62	14.53	3.76	0.68	3.08	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.95	10.03	30.08	14.22	15.13	2.73	1.64	2.37	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	21.09	17.17	26.49	15.33	14.96	1.84	1.23	3.31	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.15	15.45	23.77	13.16	18.94	1.07	1.75	4.30	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.03	10.38	29.48	10.14	14.86	2.59	2.12	2.12	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.43	18.65	27.38	15.87	12.90	2.78	1.19	2.18	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.37	17.54	22.45	10.52	13.56	2.81	2.10	3.51	3.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.22	8.71	25.50	14.10	15.34	2.70	1.66	2.70	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	12.83	19.02	21.24	14.38	13.05	2.65	2.21	3.10	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.44	17.55	23.60	12.32	13.79	3.76	1.88	3.13	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	25.30	10.23	25.03	14.40	14.40	3.36	1.88	2.96	3.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	28.78	19.58	25.37	16.86	14.65	2.72	1.02	2.38	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.26	19.09	20.44	13.30	15.42	3.47	1.35	3.47	3.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	17.71	12.55	24.59	11.00	18.05	2.75	1.03	4.99	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.26	21.81	24.28	17.83	15.77	2.19	1.51	2.88	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.03	19.54	18.22	9.52	17.24	2.30	1.15	3.94	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.29	10.06	28.63	14.32	14.49	3.07	1.36	3.58	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.89	14.35	25.74	12.87	16.42	2.37	0.59	3.70	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.59	11.46	17.06	11.73	12.53	4.00	0.80	4.00	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.71	9.26	29.87	15.07	9.54	2.35	3.18	1.52	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.52	14.05	23.81	14.29	15.95	1.19	2.38	2.86	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	24.59	18.94	22.77	18.14	15.72	7.26	1.81	2.62	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	19.12	11.02	27.40	13.37	11.49	3.48	2.26	2.17	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.61	18.17	25.85	16.42	9.43	3.49	5.24	2.45	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	27.80	12.39	28.41	11.79	6.04	8.46	1.51	0.30	4.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.97	12.85	31.09	19.70	13.46	4.77	1.71	3.06	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	30.42	17.18	18.92	11.79	11.94	9.17	3.20	3.35	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	22.51	11.56	23.73	17.04	15.21	5.48	1.22	3.65	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.32	11.15	39.48	15.37	14.17	4.52	3.01	3.62	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.37	18.10	28.27	12.21	18.55	3.39	2.04	2.49	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.75	14.08	22.47	14.08	19.77	7.49	2.40	3.59	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.83	8.38	21.25	7.56	11.69	4.84	3.19	1.53	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	35.65	19.85	20.92	9.18	15.15	3.20	2.13	3.63	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.64	15.02	18.63	12.62	22.24	6.01	3.00	3.00	1.20
Schwann Cells, donor1	11498-119F4	42.50	25.39	18.24	14.29	10.34	1.32	3.01	2.63	2.26
Schwann Cells, donor2	11578-120F3	6.80	10.21	3.40	10.21	3.40	0.00	6.80	3.40	3.40
Schwann Cells, donor3	11659-122F3	26.29	17.53	10.08	9.20	9.20	1.97	1.75	3.07	3.51
Sebocyte, donor1	11220-116B5	27.39	8.22	17.53	10.41	3.29	2.19	0.55	0.55	0.55
Sebocyte, donor2	11301-117B5	20.68	10.57	8.27	10.11	5.97	1.84	0.00	0.46	0.92
Sebocyte, donor3	11378-118B1	19.79	9.48	15.05	12.99	5.98	4.12	2.47	5.15	1.24
Sertoli Cells, donor1	11255-116F4	19.88	14.91	16.57	8.28	1.66	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	19.77	19.77	19.77	0.00	5.65	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	48.83	21.91	31.67	19.44	3.26	5.89	4.22	1.32	1.85
Skeletal Muscle Cells, donor2	11358-117H8	70.12	28.19	46.26	32.53	5.78	7.23	0.72	0.72	2.17
Skeletal Muscle Cells, donor3	11430-118G8	100.32	40.97	43.47	22.57	23.41	2.51	11.70	5.85	1.67
Skeletal Muscle Cells, donor4	11451-119A2	33.46	17.28	10.21	6.76	11.00	0.94	1.10	2.67	2.04
Skeletal Muscle Cells, donor5	11455-119A6	36.27	20.81	10.41	8.03	8.62	0.45	1.34	1.93	0.89
Skeletal Muscle Cells, donor6	11459-119B1	33.55	17.54	9.23	9.39	9.08	0.92	1.08	1.08	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.57	12.10	8.57	8.32	6.43	2.77	2.14	1.76	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.67	17.69	10.84	8.70	4.57	1.43	1.28	1.00	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.79	27.18	11.31	10.02	8.93	1.59	1.39	2.28	2.48
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	46.76	23.84	25.78	13.99	8.85	4.89	2.78	1.52	2.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	43.43	19.54	26.06	20.99	5.79	5.07	2.17	2.17	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	64.81	26.28	15.96	13.35	14.59	1.51	1.10	4.82	3.03
Skin - palm, donor1	10286-104F7	5.37	2.69	2.69	2.69	2.69	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.25	5.62	4.76	3.17	8.94	0.58	0.29	1.87	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	2.45	2.45	7.36	5.73	10.63	10.63	0.82	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.92	12.72	6.88	5.19	7.53	0.65	0.52	2.60	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	15.57	9.73	10.70	7.23	2.22	0.97	0.28	0.56	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	25.88	14.91	18.43	13.08	2.25	1.41	0.84	0.28	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	10.57	9.52	12.05	11.84	7.19	8.03	1.27	2.11	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	31.78	21.21	17.54	21.21	1.12	2.92	0.82	0.67	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.11	3.39	13.58	7.10	15.43	3.70	0.93	4.63	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.22	1.56	3.78	2.67	5.11	5.34	1.78	1.11	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.63	7.64	5.29	8.82	9.99	7.05	2.35	5.29	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.80	10.39	22.10	15.25	7.51	4.42	3.31	4.20	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.30	8.27	7.09	4.33	20.48	1.97	1.97	6.69	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	18.54	9.27	5.41	5.41	6.18	4.64	2.32	3.86	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	9.01	23.02	13.01	6.00	6.00	4.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	22.09	11.31	11.18	7.59	8.25	3.06	1.06	3.73	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.52	9.75	6.87	4.88	10.86	2.66	2.66	4.65	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.06	6.66	3.97	2.05	20.48	0.90	0.64	7.81	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	8.14	3.91	4.56	4.23	4.88	1.95	0.98	1.63	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.42	10.63	8.27	7.38	7.09	2.07	1.18	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	7.69	7.83	5.55	4.84	0.85	1.00	3.27	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	37.09	16.59	12.20	9.27	7.32	1.63	0.65	2.11	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	10.35	15.53	13.70	4.87	3.35	4.26	0.61	2.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.22	14.90	15.91	10.36	5.05	5.05	4.29	1.26	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	12.24	110.17	61.21	12.24	0.00	12.24	0.00	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.56	15.74	20.50	13.35	11.92	4.29	1.43	3.81	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.75	7.67	5.16	6.05	3.69	1.03	1.18	0.74	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.89	10.98	8.18	7.32	6.24	0.86	1.29	3.66	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.50	13.43	8.50	5.98	5.98	1.36	0.73	2.62	1.26
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.21	10.98	10.05	4.49	11.14	2.32	1.08	6.81	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	5.39	6.47	8.62	12.93	1.08	2.16	6.47	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.95	5.68	5.68	6.28	15.54	2.09	0.60	5.08	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.79	25.26	15.02	11.61	10.58	1.37	1.02	2.39	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.13	5.89	8.09	8.01	4.40	2.98	1.18	0.94	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.13	11.37	6.74	4.33	10.87	4.73	1.81	3.42	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	4.55	3.64	8.87	7.28	6.14	3.87	1.82	1.82	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	4.23	6.64	4.23	10.87	2.42	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.03	20.13	10.60	8.48	7.42	2.38	0.53	3.18	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.57	8.12	9.72	8.52	8.79	3.99	1.60	3.33	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.90	9.64	10.14	7.01	8.01	3.38	1.88	2.25	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.50	6.34	8.62	4.31	3.80	1.27	2.03	2.03	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.15	20.20	14.32	9.35	9.65	1.96	0.90	4.98	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	37.51	15.75	13.50	10.50	12.75	4.50	0.75	6.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	219.68	23.26	171.86	83.99	11.63	10.34	27.14	3.88	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	60.92	39.53	16.74	12.56	13.02	5.12	1.86	6.98	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	8.58	3.53	8.08	8.08	2.52	0.50	2.02	2.02
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.21	3.76	6.89	5.33	7.83	2.19	0.31	3.76	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	21.83	5.90	5.60	3.54	5.01	0.59	0.59	2.06	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	45.40	17.99	7.66	6.25	5.75	1.42	0.67	2.58	0.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.78	14.95	13.08	7.94	7.94	2.34	1.40	1.87	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.69	7.05	7.20	7.77	6.76	3.17	0.14	2.73	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	20.91	14.28	12.49	10.71	10.45	1.53	0.76	5.61	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	36.29	16.92	15.04	9.59	19.18	1.13	1.13	6.39	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.83	10.34	8.52	6.57	4.33	1.96	1.82	1.26	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	22.04	7.79	8.55	8.04	6.03	1.09	1.34	2.77	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	9.52	25.24	17.62	5.71	4.29	1.90	1.43	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.48	4.40	5.38	4.40	6.12	1.96	0.98	4.65	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.48	5.30	7.07	6.19	10.61	1.77	1.99	3.76	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.60	12.00	9.36	5.85	8.19	1.17	0.88	2.34	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.16	5.83	7.97	5.44	6.80	1.94	3.69	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.55	1.85	4.50	1.32	3.97	2.91	0.00	1.32	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	0.37	0.37	2.23	0.74	5.95	1.86	1.86	3.35	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3.59	1.44	1.80	1.44	4.67	2.16	1.08	1.80	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	3.41	1.14	1.99	1.99	3.12	2.56	0.00	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.39	13.79	14.57	8.27	4.73	1.18	1.18	1.18	2.76
Smooth muscle cells - airway, control, donor1	11966-126D4	5.59	2.03	2.29	2.29	6.60	3.30	2.03	0.76	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	6.39	6.79	3.59	5.59	3.99	3.99	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.30	3.34	7.94	6.27	3.76	1.67	2.09	1.67	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	26.58	6.88	6.88	5.50	6.88	1.38	1.38	0.92	1.83
Synoviocyte, donor1	11291-117A4	14.81	11.11	8.08	5.05	14.48	1.85	2.19	3.20	0.67
Synoviocyte, donor2	11368-117I9	22.80	8.55	10.73	5.36	8.55	3.35	1.84	3.18	1.34
Synoviocyte, donor3	11440-118H9	20.55	7.60	11.17	4.24	6.70	2.68	1.56	1.34	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	76.11	31.45	24.66	17.51	13.94	3.22	2.86	5.36	3.22
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	11.89	7.93	9.91	3.96	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	51.40	34.50	22.46	20.61	5.33	4.17	4.86	2.08	3.47
Tracheal Epithelial Cells, donor1	11292-117A5	23.94	14.62	10.18	7.53	2.94	1.86	0.29	0.50	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	51.80	31.70	13.53	13.53	10.44	1.93	0.39	3.48	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	21.76	19.47	17.75	3.44	2.29	1.15	1.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.47	15.50	25.84	16.24	2.46	9.60	4.92	0.74	0.74
Urethra, donor2	10319-105A4	14.39	16.19	5.40	1.80	14.39	7.19	10.79	1.80	3.60
Urothelial Cells, donor1	11520-119H8	10.89	8.77	15.41	7.70	3.98	1.86	0.00	0.80	0.53
Urothelial Cells, donor2	11600-120H7	10.41	5.61	8.41	5.61	1.20	0.40	0.80	0.80	0.80
Urothelial Cells, donor3	11681-122H7	21.55	18.57	13.75	8.94	2.52	0.46	0.69	1.38	2.06
Urothelial cells, donor0	11216-116B1	19.17	10.92	14.27	15.38	2.23	0.67	0.45	0.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	15.13	8.01	49.83	19.58	8.90	23.13	23.13	4.45	11.57
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	8.58	22.87	10.01	11.44	15.73	15.73	2.86	14.30
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.85	13.69	23.96	19.17	8.90	19.17	8.90	1.37	27.38
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.04	11.71	22.04	14.12	8.26	15.84	14.12	2.41	7.23
Whole blood (ribopure), donor090325, donation2	12177-128I8	15.69	12.20	22.08	12.78	4.65	11.62	13.36	1.74	6.97
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	5.21	28.11	9.37	9.37	14.58	19.78	0.00	15.62
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	9.18	28.45	8.26	17.44	22.03	13.77	0.00	7.34
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	7.30	22.82	17.35	5.48	14.61	13.69	0.91	27.39
Wilms' tumor cell line:G-401	10809-111A8	30.59	28.62	14.80	8.64	12.34	1.36	2.22	11.47	3.58
Wilms' tumor cell line:HFWT	10597-108E3	20.24	33.44	39.60	17.60	0.88	0.00	0.88	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	27.37	21.79	12.85	10.06	1.68	2.23	1.96	0.00	3.63
achilles tendon, donor2	10292-104G4	14.47	6.20	10.33	10.33	8.27	2.07	10.33	2.07	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	101.73	41.05	22.69	16.06	4.33	4.59	2.55	0.76	4.84
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	84.74	45.74	36.68	23.91	1.63	1.16	5.80	0.23	7.89
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	67.31	30.75	21.25	17.92	8.07	0.71	3.44	1.66	8.55
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	129.25	64.49	17.69	11.43	31.84	0.82	1.63	15.51	3.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.18	50.31	28.39	23.89	53.41	0.84	5.06	16.87	4.78
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	45.89	19.88	26.44	18.82	4.44	1.69	5.92	2.54	3.38
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.59	12.25	10.62	19.33	6.26	5.72	5.17	1.63	9.80
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	55.08	26.00	9.69	7.49	11.90	0.88	0.88	5.73	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	87.39	49.00	31.85	19.19	10.21	1.63	4.90	4.08	7.76
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	134.74	69.89	31.84	19.03	41.94	5.82	5.05	23.69	13.59
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	99.18	70.29	20.61	13.43	74.15	2.21	2.02	26.31	4.05
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	42.91	15.60	46.81	15.60	7.80	11.70	0.00	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	30.44	25.10	10.69	7.20	10.46	1.63	3.49	4.42	3.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	89.58	58.51	29.51	21.49	19.42	3.11	4.40	5.95	7.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	100.53	72.48	30.98	24.26	7.31	4.09	5.26	2.92	5.55
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	59.49	49.26	10.69	13.01	1.86	3.25	3.72	0.00	6.51
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	35.37	30.84	19.74	7.81	3.70	2.47	1.23	1.23	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	178.03	104.06	44.20	22.10	11.66	2.76	3.07	4.30	2.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	96.86	50.78	38.83	23.90	14.08	2.99	2.13	9.39	4.27
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.68	38.52	39.43	22.14	10.62	1.82	1.82	7.58	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	89.06	47.18	37.79	22.14	18.78	3.13	3.13	9.87	3.13
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	69.49	52.57	20.05	14.03	10.47	3.34	1.34	2.67	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	53.37	30.35	16.01	11.34	32.69	5.00	1.33	9.01	4.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	107.78	120.78	18.58	5.57	18.58	1.86	0.00	0.00	18.58
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	41.81	29.38	16.20	14.31	67.80	3.77	5.27	25.61	7.53
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	79.38	47.54	40.56	29.22	20.06	6.11	10.47	10.03	10.47
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	76.85	50.61	16.87	16.87	1.87	9.37	0.00	3.75	13.12
adenocarcinoma cell line:IM95m	10796-110I4	32.73	34.38	27.08	19.78	3.30	5.89	0.24	1.88	1.18
adipose tissue, adult, pool1	10010-101C1	10.39	9.00	15.98	7.29	2.48	8.07	4.50	0.31	1.71
adipose, donor1	10184-103D4	25.22	10.56	6.45	8.80	4.10	2.35	21.11	2.35	18.77
adipose, donor2	10185-103D5	68.94	63.26	16.22	18.65	2.43	2.43	18.25	0.81	11.35
adipose, donor3	10186-103D6	63.17	46.83	27.23	24.51	2.45	2.18	25.60	0.82	12.25
adipose, donor4	10187-103D7	107.48	27.74	84.07	39.87	0.00	8.67	32.07	0.87	29.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	10.10	21.62	17.04	16.73	9.47	4.10	1.26	2.05	4.42
adrenal gland, adult, pool1	10081-102A9	21.83	10.91	10.91	14.55	3.64	7.28	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	56.16	36.55	25.08	22.41	34.42	12.81	0.93	13.21	3.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.09	24.65	19.65	16.79	6.79	3.22	0.36	3.93	5.00
amniotic membrane cells, donor1	12235-129G3	30.84	24.34	20.40	18.78	6.49	1.85	1.39	1.62	0.70
amniotic membrane cells, donor2	12236-129G4	126.45	43.62	24.34	17.58	13.19	2.70	1.69	2.03	0.68
amniotic membrane cells, donor3	12237-129G5	25.92	16.20	23.57	11.78	9.13	2.36	2.36	4.12	1.18
amygdala - adult, donor10196	10167-103B5	1.19	7.11	16.60	7.11	26.09	7.11	1.19	11.86	11.86
amygdala, adult, donor10252	10151-102I7	8.52	14.19	39.54	22.71	14.80	12.37	7.10	5.47	16.63
amygdala, newborn, donor10223	10360-105E9	8.07	13.23	26.47	9.04	41.64	5.81	13.23	3.55	6.13
anaplastic carcinoma cell line:8305C	10428-106D5	18.34	9.17	15.66	13.37	5.35	3.95	1.91	0.38	1.53
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.15	14.78	18.31	15.44	25.15	3.75	0.66	10.59	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	18.71	17.04	17.04	23.72	6.68	0.67	2.34	1.34	10.69
aorta, adult, pool1	10052-101G7	8.43	9.81	12.16	7.26	7.65	5.88	7.45	1.57	3.53
appendix, adult	10189-103D9	22.51	13.58	21.35	10.87	7.76	11.26	9.70	1.16	6.60
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.63	36.11	19.95	16.85	8.60	7.57	0.69	2.75	1.38
artery, adult	10190-103E1	2.72	4.08	16.30	2.72	4.08	8.15	9.51	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	28.68	21.01	26.51	24.63	4.20	3.77	2.90	1.88	2.17
b cell line:RPMI1788	10427-106D4	17.25	12.19	23.79	19.78	4.31	7.73	1.34	0.15	4.46
basal cell carcinoma cell line:TE 354.T	10702-109G9	6.94	2.77	6.66	3.61	11.65	1.94	0.00	3.88	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.06	8.73	12.30	8.14	2.98	2.68	1.09	0.99	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	12.55	11.38	19.42	11.55	1.34	4.85	0.50	0.33	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	172.25	49.77	26.28	20.13	6.15	5.03	3.91	0.56	3.36
bladder, adult, pool1	10011-101C2	10.65	9.02	21.19	9.67	4.45	8.26	5.00	1.63	1.41
blood, adult, pool1	10053-101G8	17.72	11.07	28.79	19.93	2.21	15.50	6.64	2.21	24.36
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.99	6.85	9.42	7.71	6.85	11.99	0.86	5.14	0.86
bone marrow, adult	10192-103E3	4.72	6.07	10.12	5.40	4.72	5.40	6.75	2.02	1.35
brain, adult, donor1	10084-102B3	7.18	13.33	35.88	20.50	20.50	5.13	6.15	5.13	7.18
brain, adult, pool1	10012-101C3	7.13	9.47	27.06	11.47	12.03	5.12	6.12	6.35	4.57
brain, fetal, pool1	10085-102B4	77.47	93.50	98.84	48.09	18.70	5.34	32.06	5.34	18.70
breast carcinoma cell line:MCF7	10482-107A5	74.66	28.08	29.40	22.80	16.85	4.29	2.97	3.96	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.75	56.42	65.78	60.66	34.70	20.47	6.37	28.83	6.99
breast, adult, donor1	10080-102A8	20.83	12.63	47.35	20.83	1.26	8.21	6.31	0.63	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	24.26	32.52	21.72	18.17	3.81	4.95	1.52	1.91	4.83
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.05	21.65	5.26	8.66	9.59	4.02	1.24	2.47	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1.38	4.14	1.84	0.92	5.53	0.69	1.15	2.76	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	21.79	17.19	4.60	4.36	10.17	4.84	0.48	6.05	2.18
carcinoid cell line:NCI-H1770	10703-109H1	69.11	59.24	31.97	7.99	4.23	3.29	1.88	2.82	3.76
carcinoid cell line:NCI-H727	10735-110B6	80.29	36.75	15.09	13.89	5.47	8.75	1.86	1.09	2.73
carcinoid cell line:SK-PN-DW	10719-109I8	113.77	57.36	12.99	10.77	45.32	0.63	1.27	18.38	4.44
carcinosarcoma cell line:JHUCS-1	10642-109A3	45.78	37.53	35.14	19.16	10.11	3.46	7.45	2.66	9.58
caudate nucleus - adult, donor10196	10177-103C6	1.15	11.51	23.03	6.91	10.36	11.51	3.45	2.30	10.36
caudate nucleus, adult, donor10252	10164-103B2	6.69	14.89	21.92	13.72	13.39	15.39	5.02	4.18	8.53
caudate nucleus, adult, donor10258	10379-105H1	5.35	11.46	22.16	11.46	10.70	8.41	6.88	6.11	9.93
caudate nucleus, newborn, donor10223	10354-105E3	10.99	16.85	35.52	12.09	28.93	4.39	12.09	3.30	6.23
cerebellum - adult, donor10196	10173-103C2	0.00	8.74	84.48	17.48	0.00	49.53	14.57	0.00	20.39
cerebellum, adult, donor10252	10166-103B4	9.39	10.25	81.56	23.06	3.84	76.44	25.62	1.28	40.99
cerebellum, adult, pool1	10083-102B2	8.97	10.00	41.39	10.00	2.41	7.59	20.01	1.38	7.24
cerebellum, newborn, donor10223	10357-105E6	4.98	9.96	32.38	12.45	13.28	30.72	22.42	0.00	17.44
cerebral meninges, adult	10188-103D8	6.30	5.29	23.20	8.32	16.89	4.29	7.56	4.79	6.05
cerebrospinal fluid, donor2	10294-104G6	5.12	6.58	7.31	4.39	8.04	7.31	5.85	0.00	3.65
cervical cancer cell line:D98-AH2	10552-107I3	29.62	19.27	20.99	8.48	2.01	4.31	1.44	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	27.34	14.42	13.42	9.61	7.95	2.32	0.99	2.32	1.49
cervix, adult, pool1	10013-101C4	19.32	15.75	26.46	10.81	7.87	9.55	10.29	2.41	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	13.38	7.11	14.35	9.20	7.80	2.23	1.67	3.90	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	13.06	11.76	5.23	10.45	7.84	0.00	0.00	2.61
choriocarcinoma cell line:BeWo	10423-106C9	40.39	34.80	47.47	37.28	0.25	4.35	4.10	0.00	2.24
choriocarcinoma cell line:SCH	10785-110H2	15.89	13.31	11.58	14.17	0.25	4.81	2.22	0.12	4.44
choriocarcinoma cell line:T3M-3	10618-108G6	19.69	19.92	37.24	23.48	3.32	4.98	1.66	0.71	3.56
chorionic membrane cells, donor1	12238-129G6	10.83	14.82	18.52	17.95	5.13	1.71	0.85	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	39.87	20.48	20.78	18.99	8.55	1.49	1.49	5.77	0.30
chorionic membrane cells, donor3	12240-129G8	7.69	4.95	19.23	12.09	1.10	3.30	2.20	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	57.56	34.33	16.16	13.13	45.44	4.04	4.04	21.21	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	86.64	40.72	29.78	18.25	34.58	1.54	2.88	21.52	5.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	68.64	39.28	11.19	10.35	6.76	4.43	2.75	2.53	6.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.56	22.86	10.27	3.60	24.40	4.37	0.51	6.68	4.62
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.30	31.20	16.21	5.81	21.77	6.29	0.00	7.74	4.35
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	33.39	27.49	14.66	5.29	24.64	3.26	0.00	4.89	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	73.61	52.12	14.43	6.77	17.37	1.77	0.00	2.65	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	62.81	40.14	28.93	24.76	5.73	3.13	5.47	3.39	7.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	6.63	7.77	8.00	5.03	11.20	1.37	1.14	3.20	0.69
clear cell carcinoma cell line:TEN	10636-108I6	18.91	10.58	5.90	5.55	3.30	3.64	0.35	0.52	1.21
colon carcinoma cell line:CACO-2	10513-107D9	47.22	31.12	11.53	7.32	2.20	2.20	1.46	1.46	2.01
colon carcinoma cell line:COLO-320	10420-106C6	57.01	46.75	34.59	33.07	4.94	9.12	1.90	0.76	9.12
colon, adult, donor1	10082-102B1	77.35	42.84	33.32	8.33	5.95	8.33	9.52	2.38	1.19
colon, adult, pool1	10014-101C5	36.54	15.16	18.92	13.75	3.41	5.99	6.70	0.94	2.12
colon, fetal, donor1	10070-101I7	82.81	32.14	16.07	19.16	5.56	2.47	8.03	1.85	1.85
common myeloid progenitor CMP, donor1	12130-128D6	284.18	128.34	68.75	27.50	0.00	0.00	27.50	0.00	13.75
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	6.37	9.77	4.25	2.55	31.02	2.55	2.12	6.80	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	23.70	17.66	6.49	3.77	30.64	2.87	1.66	11.17	2.72
cord blood derived cell line:COBL-a untreated	10449-106F8	16.64	11.42	6.49	4.65	44.42	0.85	1.69	14.67	2.54
corpus callosum, adult, pool1	10042-101F6	10.06	13.27	34.61	11.28	3.87	11.61	8.62	0.88	4.42
cruciate ligament, donor2	10295-104G7	8.92	8.10	8.92	1.62	8.92	12.16	5.67	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	10.43	14.45	21.67	6.42	0.80	3.21	3.21	1.61	4.01
diencephalon, adult	10193-103E4	3.36	5.52	14.40	6.24	10.32	5.52	4.08	2.40	4.80
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.00	21.12	30.77	18.37	0.23	2.53	2.98	0.23	7.58
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.98	14.36	10.77	6.92	2.56	9.74	2.82	0.26	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	33.46	14.44	9.87	12.04	1.69	0.48	1.20	0.00	0.48
ductus deferens, adult	10196-103E7	15.95	16.45	14.45	12.96	3.49	8.47	5.98	1.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	30.24	11.52	10.08	0.00	5.76	5.76	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	14.71	11.77	22.07	11.03	5.89	2.94	11.77	2.21	3.68
dura mater, adult, donor1	10041-101F5	15.03	12.88	16.43	9.91	5.86	9.58	6.94	1.49	3.72
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	107.48	35.53	21.10	17.32	138.13	8.88	6.00	24.65	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	107.90	53.16	15.33	8.74	79.53	0.86	2.58	13.18	2.58
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	8.02	9.87	8.02	9.87	7.40	1.23	2.47	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	3.63	6.96	6.66	6.05	11.50	2.42	1.21	3.33	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.03	4.32	8.95	8.95	11.73	6.79	0.93	0.93	1.23
embryonic pancreas cell line:2C6	10603-108E9	5.25	3.94	11.82	10.51	15.76	6.57	1.31	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	17.77	13.41	7.71	7.71	4.36	2.68	1.68	2.01	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	17.04	17.40	25.92	21.39	14.32	5.80	1.45	5.26	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	4.99	5.31	9.33	9.65	0.00	0.96	0.80	0.00	0.64
epidermoid carcinoma cell line:A431	10426-106D3	27.46	17.12	12.34	10.23	3.33	3.67	0.56	1.56	1.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	16.83	10.01	11.55	6.27	2.31	1.87	0.88	0.66	0.22
epididymis, adult	10197-103E8	16.12	10.47	11.51	10.05	9.63	5.86	5.65	2.09	2.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.71	30.87	15.97	7.98	10.82	1.95	0.53	6.56	1.95
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.94	11.01	9.04	5.11	11.01	0.79	0.00	2.75	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	49.14	38.92	26.21	11.93	1.57	10.22	0.66	0.79	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.87	36.12	29.62	17.22	1.08	18.60	1.08	0.89	5.02
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	51.98	42.12	25.32	11.31	2.58	8.40	0.34	0.67	3.25
esophagus, adult, pool1	10015-101C6	18.58	12.85	20.49	9.56	3.40	5.42	3.93	1.70	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	9.39	7.14	17.28	16.53	1.38	4.01	3.76	0.00	4.13
eye - muscle inferior rectus, donor1	10272-104E2	0.00	0.00	2.41	2.41	2.41	7.24	7.24	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	6.31	0.00	6.31	4.21	6.31	6.31	6.31	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	4.46	7.44	0.00	11.91	8.93	0.00	0.00	7.44
eye - muscle superior, donor2	10297-104G9	9.17	4.59	2.29	3.44	6.88	5.73	8.03	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	7.29	8.74	5.83	7.29	2.91	5.83	0.00	5.83
eye, fetal, donor1	10054-101G9	10.42	11.69	28.73	15.51	5.85	5.34	8.39	2.03	7.12
fibrosarcoma cell line:HT-1080	10758-110E2	16.67	12.44	10.64	7.05	10.26	1.67	1.15	3.33	2.31
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.46	28.49	14.96	12.11	19.23	3.32	1.66	6.17	2.61
frontal lobe, adult, pool1	10040-101F4	6.00	14.36	26.18	10.41	20.17	7.51	5.82	7.88	8.07
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	26.42	18.62	11.71	8.11	3.30	2.10	0.90	0.90	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	5.67	6.95	6.40	4.94	2.29	1.55	0.18	0.55	0.46
gall bladder, adult	10198-103E9	21.97	10.86	17.62	10.14	8.45	5.07	4.35	2.90	1.45
gamma delta positive T cells, donor1	11937-126A2	38.65	13.96	43.49	19.86	34.90	13.96	5.91	2.15	5.37
gamma delta positive T cells, donor2	11938-126A3	32.49	11.58	40.34	21.29	23.16	11.58	11.58	1.49	6.35
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.32	12.04	9.29	6.34	9.29	5.91	1.06	2.53	2.96
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.85	20.70	14.70	8.12	5.42	2.71	1.16	1.16	3.09
gastric cancer cell line:AZ521	10549-107H9	23.45	29.18	32.14	20.99	14.10	2.95	0.82	4.92	1.31
gastric cancer cell line:GSS	10560-108A2	7.32	12.81	12.81	4.58	8.24	2.75	1.83	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.83	23.99	19.88	14.16	6.40	0.23	4.57	1.60	5.25
giant cell carcinoma cell line:LU65	10487-107B1	7.11	5.51	21.23	10.21	1.95	5.28	0.69	0.34	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	17.49	9.80	5.74	6.58	13.44	2.66	1.12	2.66	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.93	21.20	20.95	11.22	5.24	4.99	0.50	0.50	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.01	15.52	13.19	10.45	11.82	7.49	1.37	4.12	2.01
glioblastoma cell line:A172, tech_rep2	10444-106F3	23.45	15.73	12.78	9.13	12.78	7.72	1.26	5.34	1.69
glioblastoma cell line:T98G	10485-107A8	29.80	17.44	9.60	7.73	8.61	2.43	1.32	3.86	0.88
glioma cell line:GI-1	10413-106B8	70.58	14.64	13.18	8.79	4.69	2.93	2.64	1.46	0.29
globus pallidus - adult, donor10196	10175-103C4	4.37	8.02	15.31	6.56	5.83	5.83	2.19	2.92	8.75
globus pallidus, adult, donor10252	10161-103A8	9.03	14.40	30.02	14.16	4.88	20.02	9.28	0.98	6.83
globus pallidus, adult, donor10258	10367-105F7	1.37	5.48	21.91	6.85	8.22	5.48	12.32	2.74	2.74
globus pallidus, newborn, donor10223	10364-105F4	16.52	13.86	38.37	10.13	14.39	3.20	4.80	3.73	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	371.97	193.32	85.65	31.81	0.00	12.24	14.68	0.00	19.58
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	21.86	10.93	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	5.23	5.23	10.45	0.00	0.00	0.00	0.00	10.45
granulosa cell tumor cell line:KGN	10624-108H3	15.04	12.16	10.56	8.96	3.20	2.56	1.92	0.64	1.60
hIPS +CCl2, biol_rep1	14383-156B9	16.07	11.48	21.12	22.04	5.05	1.84	5.97	1.38	11.48
hIPS +CCl2, biol_rep2	14384-156C1	1.83	12.35	16.00	15.09	4.12	1.83	4.12	1.37	12.80
hIPS +CCl2, biol_rep3	14385-156C2	9.02	9.66	18.03	19.32	1.29	2.58	4.51	0.64	11.59
hIPS, biol_rep1	14380-156B6	4.31	5.75	4.31	11.50	5.75	0.00	1.44	1.44	18.68
hIPS, biol_rep2	14381-156B7	6.86	9.60	19.89	13.03	2.74	4.12	3.43	1.37	14.40
hIPS, biol_rep3	14382-156B8	5.52	4.41	20.97	6.62	9.93	8.83	8.83	1.10	6.62
hairy cell leukemia cell line:Mo	10712-109I1	30.75	22.70	17.24	15.80	23.85	3.74	1.72	1.15	4.88
heart - mitral valve, adult	10205-103F7	4.19	5.68	8.37	5.98	5.38	5.08	4.78	1.20	1.79
heart - pulmonic valve, adult	10206-103F8	6.28	6.01	18.83	5.23	3.66	10.46	4.18	1.31	2.35
heart - tricuspid valve, adult	10207-103F9	5.83	6.66	28.31	8.33	8.33	8.33	9.16	0.83	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	12.24	15.51	12.65	12.45	3.26	4.90	1.43	1.02	1.84
heart, adult, diseased, donor1	10051-101G6	1.28	5.96	7.66	5.96	2.13	5.11	2.13	1.28	2.98
heart, adult, pool1	10016-101C7	8.05	6.44	11.50	8.97	1.61	4.14	1.84	0.69	1.15
heart, fetal, pool1	10046-101G1	25.98	28.75	29.16	14.99	4.42	9.96	8.42	1.75	4.42
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.87	7.40	8.33	6.17	12.96	1.54	0.31	5.55	1.54
hepatoblastoma cell line:HuH-6	10633-108I3	59.46	34.49	9.51	7.14	0.00	9.51	1.19	0.00	10.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	77.57	59.34	33.59	23.20	1.33	1.77	2.21	0.33	6.08
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.71	55.10	35.08	25.12	0.85	2.43	2.79	0.36	5.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	76.50	56.89	38.60	26.58	0.81	4.14	2.32	0.40	7.38
hepatoma cell line:Li-7	10484-107A7	19.57	10.57	8.79	5.67	1.89	2.45	1.00	0.89	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	45.83	25.23	35.88	29.65	6.13	4.12	1.91	2.21	3.72
hippocampus - adult, donor10196	10169-103B7	3.79	5.68	18.93	9.46	12.30	10.41	2.84	2.84	9.46
hippocampus, adult, donor10252	10153-102I9	7.76	18.37	48.98	25.31	9.18	17.14	8.98	3.27	8.16
hippocampus, adult, donor10258	10374-105G5	0.50	2.49	7.97	4.48	19.42	6.97	2.99	4.48	12.45
hippocampus, newborn, donor10223	10363-105F3	14.80	20.80	44.76	13.39	25.03	5.99	12.34	1.41	6.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	11.60	4.27	16.48	18.31	5.49	0.61	11.60	3.05	10.38
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.90	18.46	32.20	33.18	2.16	1.57	11.78	0.39	11.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	23.61	19.04	27.67	25.39	2.29	1.52	15.23	1.02	9.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	86.84	68.23	22.55	21.99	0.56	3.38	33.83	0.00	18.04
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	94.76	78.75	28.40	41.57	2.32	1.55	29.44	1.29	20.40
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	66.05	52.39	19.74	20.88	2.28	2.28	23.16	0.00	18.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	53.14	34.16	19.85	15.18	2.63	3.21	16.93	0.58	7.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	71.52	56.44	23.05	22.62	4.52	1.72	19.17	0.22	13.79
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	70.49	54.64	22.94	14.60	5.00	2.50	14.60	0.00	12.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	52.33	32.68	24.63	15.39	2.84	1.66	11.60	0.47	5.68
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	75.38	56.73	33.43	26.20	2.73	0.96	18.80	0.32	9.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.84	35.01	25.59	24.91	4.04	3.37	9.43	0.00	6.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.60	16.12	24.26	23.16	2.82	2.19	9.55	0.78	7.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	15.23	20.63	31.44	1.97	0.49	7.37	1.47	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	2.62	10.47	6.98	7.85	4.36	6.98	0.00	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	122.95	89.35	30.74	42.00	4.01	1.72	26.73	0.19	17.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	96.37	64.97	25.73	40.55	6.11	1.31	27.04	1.31	17.88
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	82.46	45.98	19.99	13.49	3.00	2.50	26.49	2.50	15.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	39.19	40.13	12.25	13.94	5.09	1.32	15.07	0.94	5.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	40.47	15.01	11.82	4.55	0.91	9.55	1.36	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.59	37.59	14.10	10.96	2.82	0.63	15.66	0.00	6.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.48	32.66	18.29	13.72	4.41	1.14	16.82	0.65	6.04
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.93	31.06	15.97	12.19	9.00	0.29	14.23	0.29	5.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	36.77	29.89	23.91	10.46	4.48	1.49	20.03	0.30	10.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	28.82	21.43	26.23	28.64	3.33	1.29	12.93	0.74	7.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	26.82	31.95	35.95	2.57	1.71	7.42	0.86	11.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.70	10.62	18.37	11.84	2.04	2.45	11.02	0.41	6.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	59.50	41.19	14.79	20.07	4.22	1.41	19.01	0.70	11.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	87.42	58.60	16.15	21.22	2.53	0.95	23.12	0.63	12.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	74.14	55.38	18.16	17.25	5.14	0.91	17.55	0.61	11.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	29.48	40.85	13.96	9.83	4.14	2.07	10.86	1.03	6.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	34.54	40.51	18.60	11.95	1.99	0.66	13.95	0.00	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	28.48	26.68	13.34	9.24	5.39	1.80	13.08	1.03	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.21	28.12	13.29	12.78	6.39	1.02	14.06	1.02	7.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	21.96	24.99	9.09	2.27	0.76	17.42	0.00	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.00	29.57	15.12	12.10	5.38	1.34	14.45	0.67	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	27.77	26.08	25.60	28.26	4.35	1.69	10.38	0.24	12.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.08	20.95	26.29	15.60	3.57	0.89	13.82	0.89	8.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.83	24.39	25.85	19.02	3.41	4.39	10.73	1.46	13.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	64.49	56.23	17.42	24.45	2.44	3.06	22.00	1.53	14.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	3.25	0.00	3.25	3.25	3.25	13.01	6.51	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	33.09	15.55	8.60	6.29	3.97	1.65	25.81	0.33	9.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.69	47.07	16.42	13.14	2.74	3.28	16.42	0.00	13.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	50.30	47.41	13.03	7.96	3.26	2.17	16.65	0.36	10.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.37	32.38	13.52	9.61	2.85	0.71	11.39	0.71	10.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	28.64	15.51	13.13	3.58	0.00	11.93	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	63.38	48.35	25.46	18.15	5.15	3.11	16.25	0.54	11.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	53.34	37.98	22.09	17.78	4.31	0.27	16.16	0.00	5.93
immature langerhans cells, donor1	11904-125F5	13.32	3.39	10.17	12.35	6.78	4.36	1.70	0.73	2.66
immature langerhans cells, donor2	11905-125F6	13.47	12.67	6.34	16.63	7.13	4.75	5.54	0.79	1.58
insula, adult, pool1	10039-101F3	10.13	15.14	27.35	11.45	22.90	8.14	8.14	10.88	7.95
keratoacanthoma cell line:HKA-1	10791-110H8	74.78	41.94	19.18	12.68	3.58	0.65	0.98	1.30	0.98
kidney, adult, pool1	10017-101C8	12.02	11.41	10.91	9.61	3.50	6.71	2.10	1.10	1.50
kidney, fetal, pool1	10045-101F9	25.82	17.97	20.02	13.86	7.78	6.93	11.53	2.12	4.60
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.45	16.33	12.36	7.10	2.41	4.40	1.99	0.99	1.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	33.87	14.65	11.06	4.01	16.31	2.76	0.28	4.84	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.48	8.99	9.73	2.94	1.28	1.65	0.37	0.55	0.73
left atrium, adult, donor1	10079-102A7	6.54	9.26	6.54	8.72	1.63	7.08	4.90	1.09	1.63
left ventricle, adult, donor1	10078-102A6	5.06	8.09	11.63	5.56	1.52	1.01	4.05	0.51	1.52
leiomyoblastoma cell line:G-402	10721-110A1	49.80	24.62	12.04	8.48	23.80	1.92	1.37	9.85	5.20
leiomyoma cell line:10964C	10569-108B2	7.18	3.23	5.03	1.44	3.95	0.72	1.44	2.87	0.36
leiomyoma cell line:15242A	10570-108B3	1.09	1.09	2.17	1.63	4.35	0.54	0.00	3.26	0.00
leiomyoma cell line:15425	10571-108B4	4.13	3.89	3.89	1.94	6.07	2.19	0.49	1.70	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	6.35	0.00	6.35	0.00	6.35	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	18.82	11.50	16.73	8.36	5.23	3.14	0.00	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	58.44	32.94	15.23	11.10	57.02	2.48	2.95	26.92	5.78
liposarcoma cell line:KMLS-1	10782-110G8	18.90	8.44	6.72	7.34	9.53	5.15	1.09	2.81	0.78
liposarcoma cell line:SW 872	10726-110A6	66.77	43.74	16.81	15.47	1.95	3.66	0.61	0.73	2.92
liver, adult, pool1	10018-101C9	15.07	7.78	22.53	17.18	0.49	5.35	2.27	0.16	0.81
liver, fetal, pool1	10086-102B5	33.87	15.99	13.17	14.11	0.00	5.64	6.58	0.00	2.82
locus coeruleus - adult, donor10196	10182-103D2	6.71	10.79	23.04	10.65	4.52	4.67	4.52	1.02	4.08
locus coeruleus, adult, donor10252	10165-103B3	6.27	8.86	22.15	11.26	7.20	9.04	4.98	1.85	7.01
locus coeruleus, adult, donor10258	10375-105G6	6.21	8.18	14.11	8.18	7.90	3.10	5.92	1.69	3.39
locus coeruleus, newborn, donor10223	10362-105F2	6.73	2.94	10.94	2.52	8.41	8.41	7.57	1.68	5.05
lung adenocarcinoma cell line:A549	10499-107C4	13.56	8.30	10.10	7.61	1.52	4.01	0.00	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	110.99	66.18	29.64	22.75	12.41	23.44	2.76	4.14	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.60	25.44	4.61	5.93	4.48	2.50	0.26	0.92	0.13
lung, adult, pool1	10019-101D1	19.14	10.04	12.40	6.97	4.96	7.68	5.43	0.83	2.01
lung, fetal, donor1	10068-101I5	3.14	6.56	16.55	3.42	7.42	11.42	11.42	0.29	2.85
lung, right lower lobe, adult, donor1	10075-102A3	17.87	14.20	16.95	11.00	5.96	11.00	10.54	4.12	1.83
lymph node, adult, donor1	10077-102A5	24.14	15.15	30.30	15.15	4.73	3.79	6.63	2.37	5.68
lymphangiectasia cell line:DS-1	10727-110A7	28.93	14.68	17.97	13.37	11.62	13.37	2.19	3.29	5.04
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.70	8.15	17.81	13.28	0.45	3.32	1.96	0.00	5.74
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	2.55	5.10	2.55	7.65	4.25	3.40	1.70	0.00	0.85
mature adipocyte, donor1	12231-129F8	11.54	7.10	9.77	4.44	1.33	7.10	0.89	0.44	0.44
mature adipocyte, donor2	12232-129F9	4.15	6.02	9.75	6.23	3.94	6.64	1.66	0.42	0.83
mature adipocyte, donor3	12233-129G1	4.98	1.66	9.96	3.56	0.95	7.82	0.95	0.00	1.42
mature adipocyte, donor4	12234-129G2	5.53	5.26	10.79	5.53	1.05	8.42	1.32	0.26	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	65.52	55.99	46.94	36.93	2.14	26.92	4.53	0.48	5.96
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	5.64	15.79	6.77	21.43	7.90	0.00	5.64	11.28
medial frontal gyrus, adult, donor10252	10150-102I6	7.17	9.20	29.43	18.02	10.30	15.26	8.09	4.05	17.47
medial frontal gyrus, adult, donor10258	10368-105F8	5.08	7.94	30.18	8.90	15.88	7.31	4.45	6.99	12.07
medial frontal gyrus, newborn, donor10223	10352-105E1	3.84	5.54	21.75	3.84	59.71	2.99	7.68	9.38	11.52
medial temporal gyrus - adult, donor10196	10183-103D3	5.57	10.80	27.00	13.84	18.23	8.94	4.39	5.23	17.55
medial temporal gyrus, adult, donor10252	10156-103A3	5.94	9.55	31.20	18.04	10.40	22.50	7.00	5.09	25.68
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	5.78	3.85	3.85	28.89	0.00	5.78	0.00	17.34
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	14.35	0.00	43.06	14.35	14.35	14.35	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	12.92	20.10	36.97	15.08	67.12	2.87	8.61	7.18	7.54
medulla oblongata - adult, donor10196	10174-103C3	2.60	4.54	11.03	3.89	5.84	7.79	4.54	0.00	3.24
medulla oblongata, adult, donor10252	10155-103A2	6.97	10.37	20.59	13.93	3.25	18.58	5.11	1.08	7.43
medulla oblongata, adult, pool1	10038-101F2	8.41	9.71	17.79	8.98	6.53	7.02	5.96	2.53	2.94
medulla oblongata, newborn, donor10223	10361-105F1	11.80	13.54	33.68	13.89	5.21	12.15	4.51	0.69	6.25
medulloblastoma cell line:D283 Med	10838-111E1	54.91	49.37	37.86	30.55	22.58	2.88	6.64	3.99	5.98
medulloblastoma cell line:ONS-76	10759-110E3	39.13	25.56	9.05	5.01	9.78	2.45	0.37	2.69	1.10
melanoma cell line:COLO 679	10514-107E1	14.95	10.35	8.05	5.17	19.98	2.44	1.15	4.17	0.72
melanoma cell line:G-361	10465-106H6	27.69	17.92	7.87	3.53	20.63	2.17	1.63	2.17	0.81
meningioma cell line:HKBMM	10691-109F7	12.48	9.77	9.59	7.78	10.49	2.89	1.45	1.63	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	87.23	60.80	51.99	28.20	4.41	1.76	5.29	0.88	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	72.84	54.18	43.55	36.81	12.18	0.78	4.41	3.89	6.74
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.74	13.50	9.82	7.67	19.49	2.76	0.92	4.60	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	28.18	8.00	11.27	11.27	6.73	1.82	1.45	2.00	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	4.14	4.56	6.21	15.32	0.83	0.83	3.73	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	11.94	2.39	5.34	5.62	5.62	1.97	0.56	2.53	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.52	3.85	5.58	5.78	6.93	3.27	1.93	2.31	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.16	3.47	4.86	4.16	9.02	2.08	1.39	5.55	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.04	2.75	6.35	5.66	2.75	1.03	0.69	1.20	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.36	6.79	7.82	7.82	6.10	2.76	1.27	2.42	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	35.94	9.82	10.08	10.74	16.05	2.12	0.80	4.11	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.61	5.13	8.51	5.81	13.50	2.16	0.95	5.00	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	16.64	5.41	7.97	6.26	8.68	1.71	0.71	2.70	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.56	3.95	4.94	3.62	3.29	4.61	2.31	0.33	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	15.77	7.33	8.86	12.32	9.13	1.25	0.69	3.04	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.61	10.12	4.89	5.93	7.33	4.19	0.35	3.14	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.21	4.08	4.90	5.31	6.74	1.84	1.43	2.65	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	6.11	10.06	6.47	8.63	2.16	1.44	1.80	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.10	6.10	12.62	10.14	5.90	0.83	0.62	1.55	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	6.84	3.88	5.24	2.74	3.19	2.05	0.46	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	3.36	2.94	0.84	12.59	0.42	0.84	4.62	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.15	5.08	9.56	9.86	7.17	2.84	0.60	2.39	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.56	6.30	11.55	13.57	6.21	2.19	0.79	1.84	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.63	6.63	7.36	10.31	3.68	2.21	0.74	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.15	5.44	6.87	5.72	5.72	0.57	0.57	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	25.68	18.95	16.42	7.16	7.58	1.26	0.42	3.79	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.23	17.35	9.59	5.94	7.31	1.83	0.46	3.65	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.83	14.07	7.93	8.95	8.44	4.09	1.28	3.07	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	32.46	17.54	10.21	10.21	8.11	4.19	1.05	2.88	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	33.58	16.94	10.78	8.63	7.09	3.70	1.54	1.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.24	12.94	9.18	6.35	5.88	1.65	1.65	3.29	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	33.85	10.49	11.51	10.83	5.08	1.69	2.03	5.42	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	33.80	13.75	8.65	8.65	6.68	1.18	1.57	2.75	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	29.66	11.58	6.95	5.56	5.10	4.17	2.32	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.32	12.40	8.08	6.06	5.77	2.02	1.15	3.17	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	35.47	17.18	11.38	9.15	8.25	3.57	1.12	3.35	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	36.77	14.18	12.02	7.93	7.69	2.88	1.68	2.16	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	29.33	10.27	9.53	5.87	6.60	3.67	0.73	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.23	11.08	10.07	7.05	4.36	3.69	0.34	3.02	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.70	11.87	9.83	5.73	6.55	3.68	0.82	2.05	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	28.35	14.18	11.17	5.58	4.30	1.29	1.29	2.15	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	16.41	10.94	0.00	16.41	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49	5.16	0.00	15.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	40.92	12.99	8.44	4.87	11.37	0.97	1.30	2.60	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	5.82	7.27	4.36	5.82	1.45	0.00	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.85	19.72	9.06	5.86	5.33	1.60	2.13	2.13	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	14.72	5.72	9.00	4.91	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.20	14.77	9.72	9.33	5.83	1.94	0.39	1.94	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	18.89	8.39	4.20	6.30	2.10	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	9.93	3.97	2.98	10.93	3.97	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	14.30	0.00	9.53	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	34.98	10.08	7.12	7.71	7.71	1.78	1.19	2.37	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	13.40	4.87	8.53	7.31	3.66	1.22	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	108.21	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	36.10	15.20	3.17	6.97	6.33	1.27	1.90	1.27	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	38.97	10.00	6.55	6.90	6.21	3.10	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	45.13	6.45	8.60	17.19	8.60	6.45	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	11.98	7.98	0.00	11.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	10.33	10.33	13.78	10.33	3.44	3.44	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.49	8.15	9.78	13.04	6.52	6.52	1.63	2.85	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	11.12	11.12	10.33	12.71	4.77	0.79	3.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	6.48	11.20	9.43	8.25	2.95	2.36	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	5.30	9.66	7.79	6.55	3.43	1.56	1.56	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	6.68	10.69	5.35	6.68	5.35	0.00	6.68	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	11.83	10.64	3.55	4.73	2.37	4.73	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	20.54	7.70	2.57	12.84	5.14	2.57	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	4.13	10.33	2.07	9.64	1.38	2.75	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	14.35	8.91	7.42	5.44	3.46	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	30.28	12.34	19.07	4.49	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	10.18	12.72	6.36	2.54	2.54	1.91	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	24.18	18.94	14.10	10.48	6.04	4.03	0.40	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	26.17	30.53	8.72	8.72	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	15.20	10.14	8.87	2.53	1.27	0.00	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	47.94	12.74	16.99	12.14	3.64	2.43	3.03	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	22.59	18.08	9.04	4.52	4.52	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	38.71	11.53	21.42	12.36	3.29	2.47	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.94	15.68	11.11	3.77	6.75	1.79	1.19	1.98	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.07	12.33	11.36	6.49	9.09	1.62	1.30	3.24	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	10.19	12.22	4.07	1.02	6.11	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.04	10.06	10.06	14.70	13.93	12.38	2.32	3.09	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.12	38.27	34.96	18.66	9.21	3.07	0.00	1.89	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.05	6.95	5.33	10.66	7.18	0.93	0.23	4.63	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	0.00	4.27	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.45	4.93	5.65	2.98	5.03	0.62	1.75	3.19	0.72
mesothelioma cell line:Mero-25	10850-111F4	30.64	18.16	17.25	10.67	6.13	0.68	0.91	2.50	1.82
mesothelioma cell line:Mero-41	10851-111F5	47.43	35.20	22.49	12.47	6.85	3.67	1.22	0.49	1.22
mesothelioma cell line:Mero-48a	10852-111F6	8.86	7.97	5.76	10.19	5.31	3.76	0.66	1.33	0.44
mesothelioma cell line:Mero-82	10853-111F7	43.10	22.86	12.35	10.78	4.20	1.84	0.79	4.20	1.58
mesothelioma cell line:Mero-83	10854-111F8	28.26	15.15	9.19	9.02	7.49	0.85	1.02	2.04	0.85
mesothelioma cell line:Mero-84	10855-111F9	16.94	11.88	5.06	4.80	6.32	0.00	0.00	2.53	1.01
mesothelioma cell line:Mero-95	10856-111G1	29.61	24.64	19.88	9.94	8.49	3.31	0.41	1.86	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	19.22	14.74	12.26	9.94	2.65	0.99	0.99	0.50	1.82
mesothelioma cell line:NCI-H226	10846-111E9	15.57	7.24	6.33	5.97	4.71	0.54	0.54	0.36	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	27.50	19.47	9.91	7.17	7.86	2.22	0.17	1.88	0.51
mesothelioma cell line:NCI-H28	10845-111E8	15.52	14.00	10.18	7.38	5.85	3.31	0.25	1.53	1.53
mesothelioma cell line:No36	10857-111G2	23.16	17.94	8.48	6.20	4.89	0.98	0.98	0.65	1.63
mesothelioma cell line:ONE58	10858-111G3	11.92	8.13	7.32	5.42	6.50	1.90	0.54	1.63	0.54
migratory langerhans cells, donor1	11901-125F2	0.96	0.96	3.26	3.84	9.21	4.03	5.18	0.19	0.77
migratory langerhans cells, donor2	11902-125F3	3.30	6.59	7.08	7.33	17.46	2.93	3.18	1.83	1.22
migratory langerhans cells, donor3	11903-125F4	3.23	5.03	5.92	4.13	10.59	3.77	3.05	0.54	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	13.71	10.12	14.37	10.77	2.61	0.98	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.38	10.38	4.66	6.57	1.48	0.21	1.06	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	25.11	14.05	13.82	7.83	3.69	2.76	0.00	1.84	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.11	24.74	19.79	14.46	10.09	5.14	1.71	3.23	4.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	107.55	56.73	44.72	18.85	4.44	2.77	2.22	3.33	3.88
myeloma cell line:PCM6	10474-106I6	25.70	12.45	16.60	5.73	9.49	2.57	0.99	1.78	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	13.70	10.65	10.15	13.19	1.01	11.16	1.52	0.00	5.07
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	7.65	8.24	6.86	67.67	5.10	0.39	32.95	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	20.95	10.47	13.82	14.04	0.56	1.00	0.45	0.45	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.31	7.13	11.25	9.93	1.10	1.03	0.51	0.00	1.25
nasal epithelial cells, donor2	12227-129F4	43.61	13.25	22.63	18.22	1.66	2.76	6.07	0.00	3.31
neuroblastoma cell line:CHP-134	10508-107D4	81.44	46.93	31.29	21.40	21.17	2.07	4.83	12.19	7.36
neuroblastoma cell line:NB-1	10539-107G8	66.60	44.15	31.99	24.51	23.76	3.18	6.74	7.30	7.30
neuroblastoma cell line:NBsusSR	10607-108F4	24.04	23.62	24.46	19.82	18.77	1.90	1.05	6.12	3.80
neuroblastoma cell line:NH-12	10555-107I6	55.91	26.09	41.74	36.90	16.03	1.86	19.38	7.08	14.72
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	47.21	23.96	38.19	17.08	6.17	2.85	4.03	3.56	12.57
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	150.94	58.60	18.06	14.89	37.06	1.43	8.39	25.82	11.09
neuroectodermal tumor cell line:TASK1	10774-110F9	51.32	23.95	10.87	7.45	4.03	0.81	1.61	2.01	3.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	183.10	85.83	23.52	10.17	24.16	8.26	1.27	5.72	11.44
neurofibroma cell line:Hs 53.T	10729-110A9	39.39	24.75	14.91	11.45	11.18	2.66	1.06	3.46	1.86
neutrophil PMN, donor1	12133-128D9	74.37	29.75	29.75	0.00	0.00	14.87	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	13.28	13.28	0.00	13.28
neutrophil PMN, donor3	12141-128E8	18.94	0.00	37.88	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.27	31.63	8.79	4.23	6.43	0.17	1.69	1.01	11.16
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	71.25	16.81	5.60	7.20	3.20	1.60	0.00	5.60	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.57	16.67	14.11	9.62	14.75	2.24	1.92	1.92	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.56	6.04	4.47	3.94	6.83	2.36	1.58	3.68	0.26
nucleus accumbens, adult, pool1	10037-101F1	7.59	15.56	25.50	12.28	20.72	7.59	6.28	9.00	8.81
occipital cortex - adult, donor10196	10172-103C1	2.06	6.18	18.54	8.24	10.30	8.24	0.00	6.18	16.48
occipital cortex, adult, donor10252	10163-103B1	6.98	13.42	35.96	21.74	6.44	25.49	6.71	2.42	20.93
occipital cortex, newborn, donor10223	10355-105E4	11.28	22.56	51.32	10.92	50.22	4.37	7.64	10.55	9.10
occipital lobe, adult, donor1	10076-102A4	11.28	14.43	21.25	8.13	17.58	7.08	6.30	7.61	6.56
occipital lobe, fetal, donor1	10073-102A1	76.38	88.82	96.12	39.91	8.15	4.29	34.33	3.43	16.73
occipital pole, adult, pool1	10036-101E9	6.39	13.64	34.69	16.16	13.48	7.73	6.94	7.33	10.25
olfactory region, adult	10195-103E6	5.35	9.17	21.02	10.32	14.52	6.69	6.30	4.39	13.95
optic nerve, donor1	10277-104E7	8.00	20.01	34.02	12.01	0.00	10.01	4.00	0.00	12.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	43.97	19.25	32.35	37.25	7.52	9.68	0.23	1.82	1.71
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	9.48	10.17	6.59	7.83	9.34	1.37	1.10	3.02	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.05	10.16	5.76	3.22	4.06	2.03	0.51	0.85	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.96	16.06	7.51	9.59	1.62	2.66	0.46	0.35	1.96
osteoclastoma cell line:Hs 706.T	10704-109H2	79.37	32.63	24.40	14.11	8.23	2.65	0.59	2.35	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.03	22.42	14.02	3.74	6.54	5.61	0.00	0.93	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	100.94	26.72	16.54	13.78	12.09	1.70	1.91	5.09	1.91
ovary, adult, pool1	10020-101D2	21.23	14.68	25.86	12.49	5.15	6.03	8.91	2.10	2.18
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	21.08	17.42	7.52	4.77	5.68	2.93	0.37	1.47	1.28
pancreas, adult, donor1	10049-101G4	17.87	12.23	24.46	15.99	2.82	6.58	2.82	0.94	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	68.49	42.21	51.43	43.33	1.96	1.68	2.52	0.56	3.07
papillary adenocarcinoma cell line:8505C	10437-106E5	16.52	6.81	9.03	6.13	2.56	2.04	1.02	0.34	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.53	7.62	10.10	8.11	2.15	4.80	0.83	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	7.41	12.26	29.10	11.90	15.65	4.30	5.67	7.87	8.42
parietal cortex, adult, donor10258	10373-105G4	8.07	1.47	22.02	8.07	12.48	11.74	9.54	3.67	8.07
parietal lobe - adult, donor10196	10171-103B9	4.70	2.82	18.81	4.70	15.05	13.17	4.70	2.82	10.35
parietal lobe, adult, donor10252	10157-103A4	4.28	9.12	23.37	18.24	9.41	13.11	5.13	1.71	18.81
parietal lobe, adult, pool1	10034-101E7	5.82	10.13	28.82	11.72	14.89	6.26	5.64	6.87	5.90
parietal lobe, fetal, donor1	10072-101I9	73.71	57.22	113.47	36.85	14.55	9.70	32.00	0.97	26.19
parietal lobe, newborn, donor10223	10356-105E5	7.48	16.82	23.55	10.09	70.66	3.74	8.22	8.22	9.72
parotid gland, adult	10199-103F1	9.25	6.17	22.82	12.33	5.55	2.47	1.23	0.62	1.85
penis, adult	10200-103F2	8.06	6.98	13.96	4.30	5.91	5.91	6.98	1.61	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.80	10.60	25.66	7.44	13.02	1.30	7.25	6.14	4.09
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	23.31	17.48	9.32	9.91	6.99	3.79	0.73	2.04	1.46
pineal gland - adult, donor10196	10179-103C8	9.03	9.68	18.71	4.52	49.02	19.35	3.87	10.32	5.16
pineal gland, adult, donor10252	10160-103A7	5.33	10.07	17.17	9.48	14.21	36.12	4.15	5.33	2.96
pineal gland, adult, donor10258	10377-105G8	1.88	10.03	16.93	5.64	15.05	24.46	6.27	5.02	5.64
pituitary gland - adult, donor10196	10180-103C9	5.06	3.04	5.06	8.09	25.30	12.14	8.09	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	3.65	6.25	12.51	13.03	17.20	37.00	7.30	5.21	4.69
pituitary gland, adult, donor10258	10378-105G9	7.66	9.36	13.62	4.26	27.24	18.73	7.66	5.11	1.70
placenta, adult, pool1	10021-101D3	9.03	10.54	13.76	12.58	3.76	6.24	4.09	0.97	1.83
plasma cell leukemia cell line:ARH-77	10840-111E3	10.99	11.65	12.71	9.27	3.58	3.71	1.32	0.26	4.90
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.21	10.43	9.03	6.69	16.65	1.71	0.78	8.25	0.31
pons, adult, pool1	10033-101E6	6.37	5.08	11.45	5.16	4.73	5.16	3.36	1.38	3.53
postcentral gyrus, adult, pool1	10032-101E5	7.93	13.69	26.41	13.43	19.88	6.02	5.75	8.46	8.11
promyelocytes/myelocytes PMC, donor1	12132-128D8	376.45	142.21	62.74	35.55	2.09	16.73	4.18	0.00	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	22.03	27.54	0.00	0.00	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	11.74	0.00	11.74	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.24	15.73	8.01	6.55	1.31	0.73	0.00	0.15	0.58
prostate cancer cell line:PC-3	10439-106E7	41.20	26.32	11.07	8.35	12.52	2.90	0.73	6.53	0.54
prostate, adult, pool1	10022-101D4	24.94	16.14	22.49	8.34	8.07	6.71	6.26	2.81	2.18
putamen, adult, donor10196	10176-103C5	5.90	12.04	15.11	13.93	20.77	8.73	4.49	7.32	9.68
putamen, adult, donor10252	10152-102I8	3.92	11.76	33.33	13.73	7.84	13.73	5.88	0.00	11.76
putamen, adult, donor10258, tech_rep1	10372-105G3	0.00	5.46	10.93	7.65	3.28	3.28	1.09	1.09	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	2.90	6.77	14.74	13.05	13.29	8.21	8.94	1.45	15.22
putamen, newborn, donor10223	10365-105F5	3.00	5.25	14.24	4.50	28.49	8.25	15.74	9.00	6.75
rectal cancer cell line:TT1TKB	10469-106I1	63.71	32.88	17.75	14.26	2.33	4.95	0.87	0.58	1.45
rectum, fetal, donor1	10067-101I4	136.32	51.47	29.21	13.91	5.56	5.56	9.74	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.96	11.45	5.30	2.97	8.48	2.12	0.64	1.91	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	13.25	12.84	8.28	4.97	3.73	2.49	0.83	0.83	0.41
retina, adult, pool1	10030-101E3	15.11	12.23	20.38	10.14	12.23	12.52	5.96	4.47	5.07
retinoblastoma cell line:Y79	10475-106I7	76.90	56.38	20.52	14.81	2.60	0.52	2.08	1.04	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	11.80	17.09	9.59	7.25	16.84	0.74	0.98	7.01	2.58
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.68	30.09	14.62	17.72	8.15	4.22	1.41	1.97	6.47
sacrococcigeal teratoma cell line:HTST	10695-109G2	43.20	10.61	9.09	5.30	3.03	11.37	3.03	0.76	2.27
salivary acinar cells, donor1	11771-123I7	34.96	15.70	5.02	5.02	9.23	4.37	0.16	3.40	0.32
salivary acinar cells, donor2	11772-123I8	29.33	14.46	8.81	4.27	4.96	8.12	1.79	2.07	0.28
salivary acinar cells, donor3	11773-123I9	37.74	18.54	7.94	9.27	3.31	26.48	0.00	0.00	1.99
salivary gland, adult, pool1	10093-102C3	7.44	2.86	17.16	5.15	5.72	4.58	2.29	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.06	7.93	16.10	7.25	3.88	3.63	0.93	1.26	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	15.63	9.05	18.93	9.17	2.94	4.35	1.06	1.06	1.88
seminal vesicle, adult	10201-103F3	17.46	9.52	15.34	7.41	13.23	8.99	6.88	2.65	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	19.43	9.47	7.29	5.34	12.63	2.19	1.70	2.67	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.34	10.32	7.80	7.05	4.28	1.51	1.01	1.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	17.06	15.05	11.04	7.02	2.01	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	22.57	10.21	11.82	10.48	6.72	1.21	3.22	1.21	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	17.13	8.73	9.62	8.73	5.75	4.53	1.55	0.88	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.58	15.48	7.35	7.48	7.87	4.26	0.52	2.06	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	6.38	5.67	0.00	0.00	3.55	0.00	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	10.07	9.36	30.70	13.07	1.32	10.55	5.28	0.48	3.48
skeletal muscle, fetal, donor1	10066-101I3	68.34	39.20	35.18	14.07	2.01	5.03	9.05	1.01	3.02
skin, adult, donor1	10074-102A2	27.14	27.14	33.93	27.14	0.00	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.31	8.21	15.15	6.31	3.79	8.21	8.21	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.38	85.72	54.36	54.70	5.67	3.34	2.00	2.33	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.49	28.68	32.47	20.49	7.25	1.26	5.99	1.89	7.25
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.19	32.96	32.77	21.20	30.07	3.08	2.70	5.20	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	22.42	32.97	18.46	14.83	5.60	8.08	0.99	1.65	3.96
small cell lung carcinoma cell line:NCI-H82	10842-111E5	47.77	55.65	22.36	22.36	7.24	3.54	2.73	0.97	11.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.53	40.31	47.29	30.29	3.27	8.06	0.44	1.09	4.79
small intestine, adult, pool1	10024-101D6	32.01	18.87	24.49	19.59	3.46	9.32	5.14	1.19	2.99
small intestine, fetal, donor1	10064-101I1	40.79	27.52	18.18	10.81	2.70	3.93	4.42	0.49	4.18
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	31.80	27.18	23.59	13.34	12.82	2.56	1.54	2.05	0.51
smooth muscle, adult, pool1	10048-101G3	8.79	9.82	14.99	5.43	5.43	4.39	2.84	2.07	1.03
somatostatinoma cell line:QGP-1	10781-110G7	31.09	21.44	19.03	16.35	6.70	5.09	0.80	0.80	1.07
spinal cord - adult, donor10196	10181-103D1	5.74	12.39	23.40	10.32	1.84	5.51	4.82	0.00	4.82
spinal cord, adult, donor10252	10159-103A6	11.04	7.10	18.92	12.22	2.37	16.17	11.83	0.79	3.55
spinal cord, adult, donor10258	10369-105F9	1.38	0.69	2.08	0.00	1.38	4.84	2.08	1.38	4.84
spinal cord, fetal, donor1	10056-101H2	33.54	35.98	45.13	10.37	8.54	3.66	10.37	0.61	6.71
spinal cord, newborn, donor10223	10359-105E8	6.43	4.13	12.86	4.13	7.35	14.69	5.05	0.46	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.96	20.46	16.73	9.86	4.48	3.88	0.45	2.84	1.64
spleen, adult, pool1	10025-101D7	12.22	7.16	23.90	11.78	3.96	11.56	6.28	0.77	2.97
spleen, fetal, pool1	10044-101F8	28.13	15.41	25.03	13.98	6.36	10.96	8.26	2.78	5.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.77	8.70	15.53	9.73	3.73	12.01	2.17	1.35	3.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.39	11.01	9.87	6.65	5.13	1.90	0.19	1.52	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.28	15.38	12.58	9.78	5.59	1.75	1.75	0.70	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.60	2.35	5.86	5.47	4.69	1.17	1.56	1.56	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.51	9.34	15.76	11.37	4.16	2.36	2.93	1.91	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	65.23	36.85	14.83	9.74	36.85	2.12	0.00	8.05	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	12.27	16.08	23.69	13.12	4.23	3.81	2.12	0.42	2.54
stomach, fetal, donor1	10062-101H8	59.81	30.97	24.56	11.75	6.41	12.82	3.20	1.07	7.48
submaxillary gland, adult	10202-103F4	5.13	10.82	11.96	10.25	7.98	2.85	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	6.85	7.69	29.08	15.58	2.49	14.95	7.89	1.25	4.78
substantia nigra, adult, donor10258	10371-105G2	0.52	4.66	5.69	2.07	9.31	6.21	2.59	2.07	4.66
substantia nigra, newborn, donor10223	10358-105E7	12.72	9.19	22.61	6.36	8.48	15.54	14.13	0.00	8.48
synovial sarcoma cell line:HS-SY-II	10441-106E9	43.56	54.34	39.43	19.95	31.18	1.60	4.59	8.48	2.98
temporal lobe, adult, pool1	10031-101E4	9.83	18.73	36.62	14.41	24.75	6.27	8.65	10.94	9.49
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.12	74.79	96.87	43.45	21.37	4.99	24.22	3.56	17.09
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	28.13	38.68	59.78	24.61	14.07	4.83	18.90	2.64	10.55
tenocyte, donor1	11763-123H8	37.35	20.60	23.04	11.17	11.87	3.84	0.70	3.84	1.05
tenocyte, donor2	11765-123I1	16.40	6.10	11.45	11.83	8.39	6.10	1.53	1.53	1.53
tenocyte, donor3	11768-123I4	25.95	14.46	12.60	8.90	10.38	2.22	1.48	5.93	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.43	16.66	8.67	9.01	1.19	0.85	1.02	0.34	4.42
teratocarcinoma cell line:NCR-G1	10798-110I6	65.05	43.01	17.42	18.81	5.55	0.92	6.78	0.77	4.78
teratocarcinoma cell line:PA-1	10807-111A6	31.15	25.42	19.22	25.11	2.63	1.55	5.89	1.08	7.44
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	22.85	17.14	28.56	33.26	1.52	2.16	3.68	0.51	6.47
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.94	11.35	25.34	18.15	4.92	12.48	9.08	0.00	17.02
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	21.92	2.73	7.53	7.09	5.56	2.73	4.80	1.42	5.34
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.21	5.86	14.01	12.38	1.30	5.54	9.12	0.33	8.14
testis, adult, pool1	10026-101D8	25.45	17.82	32.32	14.17	5.05	8.70	8.38	0.75	4.29
testis, adult, pool2	10096-102C6	16.24	23.46	23.01	14.89	5.41	9.47	6.32	0.45	10.83
thalamus - adult, donor10196	10168-103B6	2.21	6.62	19.87	4.42	3.31	13.25	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	5.63	9.69	22.50	15.16	3.75	18.29	7.81	1.09	7.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	4.62	9.24	4.62	7.70	9.24	1.54	3.08	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.92	9.72	14.66	6.75	4.61	3.29	5.11	0.99	2.47
thalamus, newborn, donor10223	10366-105F6	1.15	5.75	12.08	2.30	15.53	2.88	8.05	1.15	3.45
throat, adult	10209-103G2	7.99	8.99	10.74	4.24	2.50	4.99	2.25	1.00	3.00
throat, fetal, donor1	10061-101H7	29.25	19.20	20.72	12.80	7.62	7.01	7.62	1.22	5.48
thymic carcinoma cell line:Ty-82	10803-111A2	34.18	30.01	30.41	19.48	3.78	1.19	2.38	2.38	3.38
thymus, adult, pool1	10027-101D9	148.92	65.91	76.45	44.04	7.85	4.67	18.29	1.29	8.55
thymus, fetal, pool1	10043-101F7	56.73	26.08	35.12	19.12	5.71	7.59	12.68	0.94	10.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.94	9.84	7.84	7.84	0.40	3.72	0.66	0.13	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	40.09	19.00	15.79	15.92	7.96	1.40	1.12	2.10	2.10
thyroid, adult, pool1	10028-101E1	17.36	13.34	28.18	12.32	6.35	6.72	4.29	1.59	2.15
thyroid, fetal, donor1	10060-101H6	16.87	17.67	27.68	16.35	8.44	7.91	7.91	3.69	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	15.40	6.16	0.00	0.00	6.16	12.32	3.08	0.00	6.16
tongue, adult	10203-103F5	11.63	10.70	17.44	7.21	5.35	3.72	3.49	0.00	1.40
tongue, fetal, donor1	10059-101H5	17.73	13.01	26.01	7.88	1.58	7.49	4.34	0.79	4.34
tonsil, adult, pool1	10047-101G2	23.54	13.82	14.12	9.02	8.62	10.42	5.51	1.40	4.01
trachea, adult, pool1	10029-101E2	16.61	10.06	13.99	9.90	5.48	7.69	3.52	1.39	1.88
trachea, fetal, donor1	10058-101H4	13.85	9.62	18.08	9.62	6.92	3.46	5.00	1.15	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.82	8.86	7.44	5.31	5.31	2.83	0.71	2.13	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	28.27	14.18	10.74	9.22	1.22	1.01	1.22	0.61	1.72
transitional-cell carcinoma cell line:JMSU1	10492-107B6	28.20	16.45	21.15	13.63	2.66	1.25	1.25	0.78	5.17
tridermal teratoma cell line:HGRT	10694-109G1	49.47	13.32	7.61	3.81	3.81	13.32	3.81	0.00	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.75	12.78	9.40	8.38	6.43	5.16	1.52	1.44	2.62
umbilical cord, fetal, donor1	10057-101H3	12.52	8.35	16.69	14.61	4.17	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	7.00	7.00	19.45	8.02	5.29	7.34	11.43	1.02	2.73
uterus, fetal, donor1	10055-101H1	25.60	16.89	24.06	12.80	4.61	3.58	3.58	3.58	4.61
vagina, adult	10204-103F6	10.99	7.75	43.30	17.45	3.23	8.40	5.82	0.00	1.94
vein, adult	10191-103E2	13.59	13.37	19.07	7.01	7.23	8.99	10.96	1.32	3.95
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.34	2.94	14.15	8.01	3.74	5.87	1.07	0.00	4.27